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What discharge properties are expressed by varying-sized sympathetic action potential (AP) 
subpopulations active under baseline conditions in humans and what are the governing 
mechanisms? To address this overall question the microneurographic approach was 
employed to record multi-unit muscle sympathetic nerve activity (MSNA), after which a 
continuous wavelet transform exposed APs in the recorded neurogram. Study One examined 
the role of the paravertebral ganglia on sympathetic neural discharge patterns. Through 
trimethaphan infusion under baseline conditions, this study revealed ordered de-recruitment 
of larger to smaller AP clusters, suggesting that the paravertebral ganglia contribute to the 
distribution of firing probabilities expressed by differently-sized sympathetic APs. However, 
the smallest APs were resistant to trimethaphan, suggesting non-nicotinic mechanisms 
contribute to ganglionic neurotransmission of this specific subpopulation of axons. Study 
Two investigated the synchronization of APs within the cardiac cycle and the role played by 
the paravertebral ganglia in this process. We observed that under baseline conditions ~30% 
of total sympathetic APs fired asynchronously between bursts of MSNA and asynchronous 
discharge frequency was not affected by baroreflex or apneic stress. Thus, asynchronous AP 
discharge represents a fundamental behaviour within human MSNA. Also, retrospective 
analysis of asynchronous AP data from Study One demonstrated that non-nicotinic 
ganglionic mechanisms contributed to some, but not all asynchronous AP discharge. Study 
Three probed the heterogeneity of baroreflex control over the discharge of AP 
subpopulations. Under baseline conditions, we found a subpopulation of medium-sized APs 
to express the greatest baroreflex gain, while the smallest and largest APs exhibited minimal 




sympathetic system increases total MSNA by resetting baroreflex control of medium APs to 
higher levels of activity and increasing the gain to facilitate augmented firing along with 
recruiting a subpopulation of previously silent larger APs. Overall, these studies provide new 
knowledge regarding the complex discharge patterns expressed by subpopulations of 
varying-sized sympathetic APs active at baseline, of which some express augmented firing 
during baroreflex stress. We also provide insight to the baroreflex and ganglionic 
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Summary for Lay Audience 
For humans to survive, blood pressure must be maintained within an optimal range and 
oxygenated blood flow must be delivered to vital organs such as the brain and the heart. Part 
of the brain known as the sympathetic nervous system ensures these conditions by sending 
precise messages along the nerves to communicate with the heart and blood vessels. These 
messages are made up of electrical signals called action potentials. During periods of stress 
that change our blood pressure and blood flow ¾ such as the fall in blood pressure that 
occurs when we stand ¾ the brain changes the message sent to the heart and blood vessels 
by adjusting the size, number, and timing of action potentials. This message tells the blood 
vessels to constrict and the heart to beat faster, which increase blood pressure and ensures 
blood flow to vital organs. This dissertation provided new information regarding the action 
potential messages used by the sympathetic nervous system to communicate with the blood 
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Chapter 1  
1 Introduction  
Critical to homeostasis and human survival are the sympathetic messages coordinating 
circulatory responses to physiological stress (106, 131). These efferent messages result 
from the integration of feedback signals arising from peripheral receptors and 
feedforward signals generated centrally into a network of supraspinal nuclei, with further 
processing by spinal circuits and the paravertebral ganglia (28, 37, 42, 78). Pioneered by 
Hagbarth and Vallbo in 1968 (49), microneurography provides direct access to the 
discharge patterns of the population of postganglionic c-fibres innervating the vasculature 
supplying skeletal muscle in humans ¾ muscle sympathetic nerve activity (MSNA). Due 
to the low signal-to-noise ratio, early investigations relied on the integrated signal to 
uncover the fundamental behaviours contained within MSNA: spontaneous bursts of 
activity expressing time-varying frequency and amplitude (26, 49).  
It was not until recent advances in recording techniques and signal processing that the 
action potentials (AP) underlying the integrated bursts were revealed (81, 98). Among 
low-threshold APs that are synchronized into bursts under baseline conditions, multiple 
size-related subpopulations exist, expressing heterogeneous discharge probabilities: 
medium APs fire within most bursts, while the small and large APs express low within-
burst probabilities (110). While burst frequency stems from the quantity of baroreflex-
gated periods of synchronized AP discharge, burst size depends on the number and size 
of synchronized APs (79, 101, 110). To increase total MSNA during physiological stress, 
the sympathetic system increases the activity of low-threshold APs (79) and recruits a 
2 
 
subpopulation of previously-silent larger and faster conducting APs (6). Thus, low-
threshold APs are essential for communicating circulatory adjustments necessary for 
homeostatic maintenance during baseline conditions and physiological perturbations. 
However, the discharge properties expressed by subpopulations of low-threshold APs 
remain incompletely understood and the mechanisms contributing to both differential 
firing among variously-sized APs under baseline conditions and the increase in emissions 
during physiological stress remain unclear. Therefore, the overall objective of the 
present dissertation was to investigate the behaviour and governing mechanisms of the 
low-threshold (i.e., active at baseline) sympathetic AP subpopulations. This dissertation 
tested the overall hypothesis that heterogeneous discharge behaviour exists among 
varying-sized low-threshold AP subpopulations under baseline conditions and during 
physiological stress, due to differing regulation within the sympathetic organization. 
Specific hypotheses tested in this dissertation are as follows: 
Study One 
The role of the paravertebral ganglia in human sympathetic neural discharge patterns 
Tested the hypothesis that the paravertebral ganglia contribute to the discharge 
behaviours expressed by sympathetic APs active at baseline in humans.  
Study Two 
Asynchronous action potential discharge within human muscle sympathetic nerve activity 
Tested the hypothesis that synchronous and asynchronous discharge exist among 





Baroreflex control of sympathetic action potential subpopulations during orthostatic 
stress 
Tested the hypothesis that during orthostatic stress the baroreflex confers its greatest 
effect on the gain of medium AP clusters that fire normally with high probability. If so, 
then the change in position and slope of each AP cluster’s baroreflex curve should vary 
across the distribution of recorded APs.    
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1.1 Sympathetic Nervous System  
The sympathetic nervous system, a division of the autonomic nervous system, maintains 
homeostasis and supports survival by communicating integrative physiological responses 
to both spontaneous and stress-imposed deviations in blood pressure and blood flow (17, 
24). Key to homeostatic maintenance are rapid alterations in sympathetic discharge 
destined for the heart and vasculature that enable modifications in cardiac output and 
vascular resistance (104, 131). While anticipatory feedforward adjustments participate in 
circulatory regulation, negative feedback circuits represent the critical element underlying 
short-term sympathetic regulation and circulatory homeostasis (44). According to the 
homeostat model (44), peripheral receptors initiate feedback reflexes as they ‘monitor’ 
the internal environment, relaying information centrally regarding blood pressure and 
volume, the chemical environments of the blood and muscle, and lung stretch, among 
other signals (37). A network of central nuclei establishes a ‘set-point’ for each 
physiological variable, such that when sensory nerves communicate a deviation from this 
level the system adjusts sympathetic outflow to modify effector organ function 
appropriately to correct the error (44). As such, sympathetic messages directed towards 
the circulation are goal-oriented and graded to the level of stress (106).  
Even the earliest views of integrated physiology predicted that the neural organization of 
complex organisms reflexively maintain vital properties of the internal environment or 
milieu intérieur in response to the “colossal forces, often adverse”, surrounding the body 
(17). As an example, while not apparently colossal, even the gravitational force 
experienced during standing imposes a redistribution of 500 to 1,000 mL of venous blood 
to the lower body, primarily in the abdominal cavity and buttocks, that if not 
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compensated for results in loss of consciousness subsequent to compromised cardiac 
output, hypotension, and reduced cerebral perfusion (107). However, in a healthy system, 
reductions in the distension of baroreceptor harbouring vessels linked to falling blood 
pressure withdraw baroreflex-mediated sympathoinhibition to increase sympathetic 
outflow to the heart and vasculature (104). Along with the concurrent parasympathetic 
response, enhanced sympathetic discharge elevates cardiac output by increasing heart rate 
and myocardial contractile force (12). Simultaneously, elevated sympathetic drive 
increases vascular resistance to augment blood pressure and venous return by limiting 
peripheral blood flow (12). Nonetheless, the contemporary understanding of 
neurocirculatory homeostasis appreciates rhythmic oscillations, in blood pressure for 
example, produced by an interaction of feedback pathways, even in supine resting 
conditions (63). 
Alteration of sympathetic regulatory mechanisms produces chronically elevated 
sympathetic outflow which relates to a host of cardiovascular pathologies. Sympathetic 
outflow directed towards skeletal muscle vasculature (i.e., MSNA) increases with age 
(116) and while no relationship exists between baseline MSNA and mean arterial 
pressure in young individuals, these variables express a positive association from about 
middle-age onwards (87). Accordingly, middle-aged and elderly patients with 
hypertension commonly display elevated MSNA (46). Interestingly, younger individuals 
diagnosed with essential hypertension also express high sympathetic activity (46) 
suggesting deteriorations in the mechanisms buffering MSNA and blood pressure [e.g., 
inverse relationships between MSNA and cardiac output/vasoconstrictor responsiveness 
(19, 20)] in normotensive counterparts. Also, consistently elevated MSNA associates 
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with heart failure (73), coronary artery disease (4), obstructive sleep apnea (108), chronic 
renal failure (47), and metabolic syndrome (56) among other conditions (46, 104). Thus, 
despite being an integral component of homeostatic maintenance, deterioration of 
sympathetic feedback pathways or allostatic modifications shifting the feedback reflex to 
a new set-point, adversely affects overall health (43).  
1.2 Sympathetic Neurocircuitry 
The sympathetic neural messages ultimately communicating the appropriate circulatory 
responses to physiological stress are a product of the central and peripheral organization 
of the sympathetic nervous system (59). Because the arterial baroreflex has received the 
bulk of research attention (12, 23), the impact of each nuclei comprising this pathway on 
sympathetic discharge is established. However, many non-baroreflex processes (and 
neural behaviours) also warrant discussion as they exist within the sympathetic 
organization and shape sympathetic outflow (112). The following discourse provides a 
non-exhaustive overview of the neural architecture of the sympathetic nervous system.  
1.2.1 The Baroreflex 
Baroreflex regulation of sympathetic and parasympathetic activity ensures maintenance 
of blood pressure within an optimal narrow range. Two divisions of the baroreflex exist: 
1) the arterial (or high-pressure) baroreflex, which relies on baroreceptors located in the 
carotid sinuses and aortic arch to signal blood pressure changes to the brain; and 2) the 
cardiopulmonary (or low-pressure) baroreflex, initiated by baroreceptors in the right 
atrium and ventricle along with pulmonary vessels communicating blood volume and 
cardiac filling pressures (32, 37). Dispersions in transmural pressure evoking tissue 
7 
 
stretch alter the firing rate of mechanosensitive baroreceptors (58). Overall, the 
baroreflex ensures negative-feedback such that increased transmural pressure within 
baroreceptor-harbouring regions modulates sympathetic outflow and augments 
parasympathetic discharge. These neural changes increase total peripheral resistance and 
cardiac output sufficiently to maintain mean arterial pressure during orthostatic stress, 
with alterations in resistance representing the primary mechanism (32). Briefly, the 
fundamental baroreflex neurocircuitry in the brainstem relies on the nucleus tractus 
solitarius (NTS) which in the pathway subserving parasympathetic regulation, NTS 
neurons send excitatory projections (releasing glutamate) to the preganglionic 
parasympathetic neurons in the nucleus ambiguus and the dorsal motor nucleus. In the 
pathways subserving sympathetic regulation the NTS sends excitatory projections to 
caudal ventrolateral medulla (CVLM) neurons, which in turn, send inhibitory signals 
(releasing g-amino butyric acid; GABA) to pre-sympathetic neurons within the rostral 
ventrolateral medulla (RVLM) (12, 109). This neural pathway has received the majority 
of research attention and while it strongly shapes sympathetic discharge behaviour, it 
does not represent the entirety of the central sympathetic circuitry (8, 23, 105).  
The baroreflex primarily defends blood pressure during standing (and as reviewed 
elsewhere (86, 95), during physical exercise), but in the laboratory orthostatic stress may 
be imposed by Valsalva’s Manoeuvre, head-up tilt, pharmacological infusions (e.g., 
sodium nitroprusside), or lower body negative pressure (LBNP) (89). LBNP enables 
investigators to titrate the degree of orthostatic stress, unload all baroreceptor 
populations, and prevents participant movement, enabling simultaneous 
microneurographic recordings under closed-loop conditions (89). Once investigators 
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secure the participant’s lower body within an air-tight chamber, chamber decompression 
to sub-atmospheric pressures induces a redistribution of blood from central regions (i.e., 
abdomen and thorax) to the venous system of the lower body (i.e., splanchnic circulation, 
buttocks, thighs, and legs) (136). The magnitude of venous pooling scales to LBNP 
magnitude. Mild LBNP (e.g., ≤ -20 mmHg) evokes venous pooling sufficient to reduce 
central venous pressure and unload cardiopulmonary baroreceptors, with negligible 
impact on stroke volume and cardiac output, leaving arterial baroreceptors unperturbed 
(68). Interpretations of autonomic responses to mild LBNP should be made with caution 
however, as Taylor and colleagues (122) observed reduced ascending aortic diameters 
during -5 mmHg LBNP, suggesting aortic arch baroreceptor unloading even during 
conditions where pressure is unchanged compared to baseline (70). LBNP greater than 
approximately -20 mmHg reduces venous return sufficient to modulate stroke volume, 
cardiac output and pulse pressure (due to reductions in systolic pressure); this stress 
unloads both cardiopulmonary and arterial baroreceptor populations (68). 
Cardiopulmonary baroreflex stress increases sympathetic discharge destined for the 
periphery, whereas arterial baroreflex unloading increases sympathetic discharge directed 
towards the heart and visceral vascular beds (1).  
1.2.2 Non-Baroreflex Sympathetic Neurocircuitry 
The collection of pre-sympathetic neurons within the RVLM are vital to the generation of 
pre- and post-ganglionic discharge based on anatomical evidence of RVLM projections 
to preganglionic neurons (112) and the consistent observation that destruction of RVLM 
cells in anaesthetized felines results in a large drop in blood pressure (48). As outlined 
above, RVLM neurons are integral to the baroreflex neurocircuitry and are strongly 
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inhibited by the CVLM during baroreflex loading (12). This CVLM inhibitory feature is 
reduced during baroreflex unloading accompanying orthostatic stress, enabling elevated 
sympathetic outflow from the RVLM (12, 78). Thus, other neural mechanisms generate 
the RVLM activity critical for preganglionic sympathetic discharge and ultimately the 
postganglionic AP behaviour observed in microneurographic recordings.  
Researchers have proposed two primary hypotheses to explain RVLM discharge. The 
pacemaker theory suggests that intrinsic depolarization of some RVLM neurons drives 
sympathetic outflow (25). Using both intracellular and extracellular recordings, Sun and 
colleagues observed rhythmical pacemaker-like discharge of rat RVLM neurons under 
conditions where excitatory neurotransmission had been pharmacologically reduced or in 
the absence of excitatory postsynaptic potentials (EPSP) (114, 115). Alternatively, the 
network theory holds that excitatory and inhibitory synapses arising from several groups 
of neurons affects RVLM behaviour (23). In support of this concept, Lipski and 
colleagues found no evidence of rhythmical membrane depolarization of rat RVLM 
neurons preceding AP discharge, but rather observed EPSPs to drive spiking, indicating 
excitatory synapsing (75). Indeed, anatomic and functional studies have revealed that the 
RVLM participates in sympathoexcitatory reflexes (e.g., chemoreflex, metaboreflex) and 
receives synaptic inputs from a host of neurons beyond the CVLM (many of which form 
an interconnected network) including the NTS, periaqueductal gray, caudal vestibular 
nucleus, lateral tegmental field, periventricular nucleus (PVN) and lateral nucleus of the 
hypothalamus, the mesencephalic locomotor region, the amygdala, medial prefrontal 
cortex, and insular cortex (8, 23, 128).  
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The influence of some non-baroreflex sites on sympathetic discharge patterns have been 
revealed by direct stimulation studies in animals and humans. For example, chemical 
stimulation of the hypothalamic PVN in anaesthetized rats increased the amplitude but 
not the frequency of integrated bursts of renal sympathetic nerve activity (83). This effect 
may be mediated by synapses with the RVLM (8, 22, 138); however, axons arising from 
some cells within PVN of the hypothalamus also bypass the medulla and synapse directly 
with spinal sympathetic preganglionic neurons at multiple levels (e.g., preganglionic 
nerves ultimately supplying the heart and adrenal gland) (11, 23, 61). Similarly, electrical 
stimulation of the dorsolateral periaqueductal gray via implanted electrodes in humans 
increased the proportion of larger bursts of integrated MSNA compared to baseline 
conditions, but did not affect burst frequency (119). Interestingly, in addition to 
synapsing with the RVLM, periaqueductal gray neurons are also reciprocally connected 
the hypothalamus (11), suggesting that the effect seen in humans may have occurred 
through hypothalamic activation. As discussed below, changes in MSNA burst frequency 
can be explained by arterial baroreflex regulation while factors affecting burst size — a 
function of the number and size of synchronously firing APs — remain to be elucidated 
fully (66, 110, 117).  
1.2.3 Sympathetic Preganglionic Neurons 
The cell bodies of sympathetic preganglionic neurons reside in the spinal cord, forming 
clusters primarily located in the intermediolateral cell column, but also in the central 
autonomic area lying dorsolateral to the central canal, in the intercalated nucleus between 
the intermediolateral cell column and the central autonomic area, and in the white matter 
of the dorsolateral funiculus (76, 113). Preganglionic neurons possess dendritic 
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arborizations broad enough to facilitate connections between neuronal clusters on 
ipsilateral and contralateral sides of the spinal midline (27, 127), which may contribute to 
synchronicity among postganglionic APs in each nerve (110) as well as bursting 
coherence in bilateral limb recordings (30). Also, cell bodies and dendrites of 
neighbouring preganglionic neurons form electrical synapses known as gap junctions 
which enable electrically-coupled networks and synchronous firing (28). Large dendritic 
fields accept both excitatory and inhibitory synapses from supraspinal nuclei which 
primarily generate their activity, along with sensory inputs emerging from the muscle and 
skin (23, 76). Importantly, preganglionic activity results from a complex spinal network 
formed by interneurons receiving input from all sensory nerves and some supraspinal 
regions (28).  
In addition to classic neurotransmitters (e.g., glutamate) synaptic inputs release a variety 
of peptides [e.g., neuropeptide Y (NPY), substance P, angiotensin II, oxytocin] and 
catecholamines [e.g., norepinephrine (NE)] that may affect preganglionic excitability (23, 
28). Indeed, some feline intermediolateral preganglionic neurons exposed to NE 
expressed rhythmic oscillations in membrane potential independent of synaptic input 
suggesting the potential for conditional pacemaker activity (137). Several other studies 
support the idea that preganglionic neurons or a spinal network contributes to 
sympathetic discharge recorded from postganglionic nerves. For example, in spinally 
transected (cervical level) rats, lumbar sympathetic discharge at the 2-6 Hz rhythm was 
restored following application of an excitatory amino acid, suggesting that supraspinal 
inputs are necessary for generating sympathetic outflow but some discharge 
characteristics are generated by preganglionic networks (2). Preganglionic neurons are 
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myelinated and emerge from the ventral spinal cord via the white ramus (132) and while 
most project to the ganglion at the same spinal level, others project either rostrally or 
caudally to synapse at nearby ganglia (113).  
1.2.4 The Paravertebral Ganglia 
The paravertebral ganglia describe the neural chains running parallel to the vertebrae 
where c-fibre cell bodies are organized into clusters and receive synaptic input from 
preganglionic nerves projecting from the spine (84). Through patterns of divergent and 
convergent synaptic organization the ganglia ensure that central sympathetic messages 
are faithfully distributed to peripheral targets but may also be integrated and modified 
accordingly (42). The ganglia amplify the distribution of the centrally arising message 
through divergent connections, which describes the synaptic phenomenon where each 
preganglionic neuron synapses with multiple postganglionic neurons (41, 59). While the 
pattern of divergence varies between ganglia and the volume of target tissue, estimates 
suggest that one preganglionic neuron synapses with a pool of about 100 postganglionic 
neurons in humans (31). Theoretically, divergence may contribute to synchronized 
discharge among postganglionic nerves as multiple c-fibres can be depolarized by the 
same input signal. Also, the recruitment of one previously-silent preganglionic neuron 
may represent a simple strategy for increasing the number of synchronously firing 
postganglionic nerves.  
Convergence defines the pre-to-postganglionic nerve organization where each 
postganglionic neuron receives inputs from multiple preganglionic axons (84). This 
feature enables the ganglia to serve as an additional juncture for integration rather than 
strictly relaying information. Each postganglionic cell body receives between 2 and 15 
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preganglionic inputs (94). However, among preganglionic inputs to a single 
postganglionic nerve, the strength or ability to evoke postganglionic discharge varies and 
may be classified as primary (strong) or accessory (weak) inputs (59). While earlier 
studies indicated that postganglionic firing resulted only from the activity of primary 
inputs, recent studies including those performed in vivo in mammals have revealed that 
integration of convergent accessory inputs augments the firing rate of the postganglionic 
nerve beyond that evoked invariably by the primary input (13, 65, 96). For example, 
evidence suggests that postganglionic APs may be evoked by a pair of accessory inputs 
firing near simultaneously or a single accessory input firing twice in rapid succession (55, 
65). Intriguingly, there also exists a subpopulation of accessory inputs whose strength 
fluctuates over time but often generates sufficient depolarization to drive postganglionic 
firing (13, 96). Synaptic convergence may contribute to the complexity of sympathetic c-
fibre discharge as the number of preganglionic synapses scales with dendritic surface 
area, which relates to neuronal size (41). Therefore, larger neurons are expected to 
receive a greater number of preganglionic synapses (excitatory and inhibitory), 
potentially from different subpopulations of spinal nerves.   
Pre-to-postganglionic transmission occurs mainly via cholinergic mechanisms at the 
ganglia. AP arrival at the preganglionic axon terminals initiates an intracellular cascade 
resulting in acetylcholine (ACh) release into the synaptic cleft (45). ACh molecules 
surviving breakdown by acetylcholinesterase in the cleft may bind to nicotinic receptors 
located on the dendritic and somatic surfaces of the postganglionic neuron (NN nicotinic 
receptors) (129). These nicotinic receptors are ligand-gated ion channels that undergo 
conformational changes upon ACh binding, enabling channel opening and sodium (Na+) 
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influx (45). Depolarization of the cell body, known as a postsynaptic potential, is 
responsible for generating an AP but only if this depolarization or the sum of the 
postsynaptic potentials reaches the threshold for AP initiation (~ -50 mV) (92). 
Postsynaptic potentials arising from cation influx are known as EPSPs but inhibitory 
postsynaptic potentials also exist, reducing the likelihood of AP generation (92). While 
nicotinic receptors represent the primary mechanism for postganglionic firing, ACh may 
also bind muscarinic receptors which are expressed on some postganglionic neurons (59, 
129). Unlike nicotinic mechanisms, muscarinic receptor binding by ACh results in a 
slower EPSP due to the G-protein coupled structure and required intracellular signaling 
cascade to initiate postsynaptic potentials (132).  
The paravertebral ganglia also exist as a site for non-cholinergic neurotransmission. 
Many preganglionic neurons contain chemical co-transmitters that are released with ACh 
and postganglionic synaptic targets expressing the appropriate receptor. According to the 
neurochemical coding hypothesis (41, 84), co-transmitter release varies by neuron and 
links to the functional sub-type of pre-and-postganglionic nerves (39). Many co-
transmitters have now been identified including (but not limited to): adenosine, adenosine 
tri-phosphate (ATP), dopamine, GABA, nitric oxide, NPY, and substance P (28, 132). 
Co-transmitter release represents a further option for postganglionic activation or 
inhibition; however, in many cases this appears to occur through slow postsynaptic 
potentials which affect postganglionic activity directly along with facilitating or 
modulating depolarization by fast EPSPs (52, 84, 129). Also, due to their position outside 
the blood-brain barrier (132), the ganglia are exposed to a variety of circulating 
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substances (e.g., angiotensin II) that may affect neurotransmitter release or 
postganglionic excitability in a similar manner (18, 38).  
1.2.4.1 Postganglionic Nicotinic Blockade: Trimethaphan 
In humans and lower animals, ganglionic neurotransmission via nicotinic mechanisms 
can be abolished through pharmacological intervention. Trimethaphan camsylate 
(Arfornad) is a selective nondepolarizing competitive antagonist of postganglionic 
nicotinic receptors (97). The onset of nicotinic blockade occurs within 1 to 5 minutes and 
lasts about 10 minutes (26, 126). Administration occurs by intravenous infusion with 
doses starting at 0.5 – 1 mg/min. Clinically, trimethaphan was used for blood pressure 
management during surgery but was discontinued and now the remaining supply exists 
for physiological research (135). Nicotinic ganglionic blockade may be verified by 
negligible (< 5 bpm) heart rate responses to Valsava’s Manoeuvre or by the absence of 
integrated MSNA bursts in microneurographic studies (7, 9). Importantly, nicotinic 
blockade via trimethaphan infusion revealed the efferent nature of MSNA (26) and 
insight to sympathetic circulatory control in humans (21, 62). 
1.2.5 Sympathetic Postganglionic Neurons 
Sympathetic postganglionic neurons exit the paravertebral ganglia via the gray ramus, 
projecting towards cardiovascular end-targets. Microneurographic recordings for the 
studies comprising this dissertation were made from the peroneal (also called the fibular) 
nerve, a branch of the sciatic nerve arising from the lumbosacral plexus (4th lumbar 
segment to 3rd sacral segment) (123). Tyrosine-hydroxylase (i.e., enzyme for 
catecholamine synthesis) stained postganglionic axons obtained from the peroneal nerve 
of human cadavers revealed that these nerves do not form their own fascicles but are 
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organized in bundles among myelinated nerves ranging in number from 1 to about 45 
axons (median: 5 axons) (124). Sympathetic c-fibres range in size from 0.5 to 2 µm 
(124), supporting the observation of varying-sized APs (confirmed by conduction 
velocities) within human multi-unit recordings (106). This dissertation focuses on the 
postganglionic axons within the peroneal nerve that are directed to vascular smooth 
muscle supplying skeletal muscle. Postganglionc c-fibres traverse arteries as they branch, 
forming a plexus within the adventitia and interface the smooth muscle via bulging 
varicosities containing synaptic vesicles then continue on and form varicosities distally 
(133). This organization, referred to as synapse en passant, enables a single 
postganglionic nerve to innervate a large volume of the vasculature (132). Size variability 
among postganglionic c-fibres may confer graded vasoconstrictor control as larger 
neurons innervate a larger vascular field in guinea pigs (40).  
Fundamentally, AP arrival at the varicosity depolarizes the cellular membrane opening 
voltage-gated calcium channels to initiate calcium influx, which causes vesicular 
exocytosis and neurotransmitter release (132). Briefly, the primary neurotransmitters 
released by sympathetic nerve varicosities are NE, NPY, and ATP (133). The major 
source of vasoconstriction for NE results from binding postsynaptic alpha-1 (a1R) and 
alpha-2 (a2R) adrenergic receptors on the smooth muscle (104). For NPY and ATP, the 
receptors primarily mediating vasoconstriction are the NPY Y1R and P2X1 receptors, 
respectively (104). a1R activation results in calcium release from the sarcoplasmic 
reticulum via Gq-protein related phospholipase C production, subsequent inositol 1,4,5-
trisphosphate (IP3) production and sarcoplasmic IP3 receptor binding (90). 
Neurotransmitter binding of NPY Y1R and a2R inhibit cyclic adenosine monophosphate 
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(cAMP) production via Gi-protein related attenuation of adenylyl cyclase activity (133). 
A reduction in cAMP activates myosin light chain kinase which phosphorylates myosin 
light chain to cause vasoconstriction. Last, P2X1 receptors are inotropic and activation 
enables calcium influx, cellular depolarization and vasoconstriction (118).  
1.3 The Action Potential  
The AP represents the fundamental neural signal enabling the sympathetic system to 
communicate with the circulation. The prototypical AP arising from an unmyelinated 
sympathetic c-fibre axon has a triphasic shape lasting one to two milliseconds in duration 
that represents phases of membrane depolarization, repolarization and hyperpolarization, 
and the return to resting membrane potential (54). APs are commonly described from the 
perspective of intracellular preparations such as those revealing the first AP recordings 
from the giant axons of squid by Hodgkin and Huxley (53, 54). Due to the relative 
abundance of potassium ions (K+) in the intracellular fluid, and relative abundance of Na+ 
and chloride ions (Cl-) in the extracellular fluid along with the large concentration of 
open resting K+ channels which facilitate K+ diffusion, most axons express a resting 
membrane potential of about -60 to -70 mV (10, 92).  
Changes in the permeability of these ions facilitated by voltage-gated Na+ and K+ 
channels underlie AP generation. At the resting membrane potential, voltage-gated Na+ 
channels are closed and passive spread of the AP depolarization at an upstream adjacent 
axonal segment initiates channel opening leading to inward Na+ diffusion and rapid 
depolarization of this region (i.e., the intracellular fluid becomes more positive resulting 
in an AP upstroke) (77). Voltage-gated Na+ channels close at peak depolarization and 
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remain inactivated for several milliseconds contributing to the refractory period of the 
axonal segment which ensures orthodromic AP conduction (10). Cell depolarization 
triggers transient voltage-gated K+ channel opening leading to K+ efflux causing 
repolarization (i.e., the intracellular fluid becomes negative resulting in an AP 
downstroke) and hyperpolarization (i.e., the intracellular fluid transiently becomes more 
negative than the resting membrane potential) then returns to the resting membrane 
potential (92). The AP hyperpolarization phase also produces a refractory stage, 
contributing to orthodromic conduction (77). Because the tip of the microelectrode used 
in microneurographic recordings is up to 10-fold larger in diameter than c-fibre axons 
(124), recordings in humans yield extracellular sympathetic APs, which express the 
reciprocal waveform to that described above (81, 98) 
1.4 Muscle Sympathetic Nerve Activity 
MSNA, postganglionic c-fibre discharge directed towards the skeletal muscle 
vasculature, represents a critical neural avenue for homeostasis. In humans, the 
microneurographic technique enables continuous MSNA recordings from superficial 
nerves (49). Briefly, microneurography involves inserting a tungsten microelectrode 
trans-dermally into a peripheral nerve and delicately manipulating the electrode to 
position its tip, and recording field, near a discharging bundle of postganglionic axons 
(106, 125). Populations of varying-sized postganglionic nerves depolarize synchronously, 
or at about the same time, due to strong phasic baroreflex-inhibition accompanying 
pressure variations across the cardiac cycle (26). This bursty behaviour represents a 
cardinal feature of MSNA.  
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Consistent with the first microneurographic recordings by Hagbarth and Vallbo (49), 
MSNA is commonly measured at the multi-unit level, capturing the activity of a 
population of c-fibres rather than individual nerves. Due to the low signal-to-noise ratio 
of sympathetic recordings, after signal amplification (50,000 to 100,000x) and filtering 
(700 – 2,000 Hz band-pass), researchers often derive metrics of sympathetic activity from 
the integrated neurogram (51, 134). Inspection of the integrated neurogram reveals bursts 
of MSNA that vary in size and occurrence under baseline conditions (49, 130). Integrated 
bursts typically express latencies, i.e., the time from the R-wave corresponding to the 
systolic pulse terminating the burst to the burst peak, between about 1.2 and 1.5 seconds 
(35) and stems from all components of the sympathetic organization with most influence 
arising from the conduction velocity of unmyelinated postganglionic nerves (~1.1 m/s) 
(34, 35). Because burst size stems, in part, from the proximity of the recording electrode 
to a c-fibre bundle and micro-electrode position can vary across an experiment, many 
studies have solely examined burst frequency (51). While the strong intra-individual 
repeatability over months confers utility to this metric (36, 67), the singular focus on 
burst occurrence exposes insight to baroreflex mechanisms but conceals additional, 
broader properties of the sympathetic nervous system (106). Based on the observation 
that burst size was inversely related to its latency (130): that is, larger bursts expressed 
faster conduction velocities than smaller bursts, Wallin and colleagues suspected that 
modifiable central synaptic delays and/or subpopulations of larger and faster-conducting 
axons may exist. This early hypothesis suggested that provided microelectrode position 
remains stable, burst size (or amplitude) may reflect the number and size of 
synchronously discharging postganglionic axons.  
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Advances in the microneurographic technique, high quality recordings, and signal 
processing strategies have enabled access to the actual sympathetic neural signal — the 
AP (80, 104, 106). Macefield and colleagues were the first to reveal the firing properties 
of individual vasoconstrictor fibres in humans (81). Reductions in the recording field 
accompanying high impedance electrodes (e.g., 10 vs. 3 MW) enabled this group to track 
the activity of APs arising from one (i.e., single-unit) or a few axons in close proximity to 
the microelectrode tip. An important consideration with this technique remains that a 
single-unit may be generated by two close-proximity axons with identical morphology, 
though investigators suspect this describes a low-probability occurrence (80). This 
technique exposed that in healthy participants, individual c-fibres fire in few cardiac 
cycles (~30 %) and most often they fire only once in an integrated burst but can fire more 
than 4 times in a burst (81). During an end-expiratory apnea, single-units fired in a 
greater proportion of cardiac cycles and expressed an increased probability of firing more 
than once per burst (79). However, multiple within-burst firing could not explain fully the 
increase in integrated burst size, furthering the hypothesis that recruitment of previously-
silent larger and faster conducting axons may represent the primary mechanism for 
augmented burst size (79).  
To test the hypothesis that a subpopulation of previously silent, larger and faster 
conducting sympathetic axons are recruited during physiological stress requires APs to be 
detected and extracted from the multi-unit neurogram. Two wavelet denoising techniques 
(16, 29, 98) and a mixed separation template-matching model (120) have been designed 
to interrogate the multi-unit signal; however, most research has employed the wavelet 
model constructed from real human muscle sympathetic APs (98, 110) and therefore the 
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present dissertation will focus on this technique and related outcomes. Briefly, this 
technique relies on a mother wavelet that was based on the mean AP template constructed 
from real human muscle sympathetic APs (98). Using a continuous transform of the 
filtered neurogram, the approach identifies the exact location of individual APs and 
extracts them from the surrounding noise (98). Using a 32-point K-means approach 
families of similarly-shaped APs are clustered based on their overall shape, primarily 
reflecting the peak-to-peak amplitude (98). Subsequently, APs can be organized into bins 
(i.e., clusters) manually or based on Scott’s rule (102). When used to compare multi-unit 
data obtained during a baseline condition and a period of physiological stress, this 
approach enables investigators to make inferences regarding the recruitment of 
previously-silent larger APs (i.e., high-threshold) or the enhanced firing of previously-
active APs (i.e., low-threshold), provided a constant micro-electrode position. Also, this 
method exposes the temporal characteristics of individual APs: relative to adjacent APs, 
the beginning of an integrated burst, and the R-wave associated with the systolic pressure 
inhibiting the coinciding burst (98). Figure 1.1 provides an overview of wavelet method 






Figure 1.1 Overview of the stages involved in extracting sympathetic action potentials 
(AP) from the filtered neurogram using the continuous wavelet transform (98) including 
signal processing, clustering, and binning.  
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The wavelet approach has illustrated diverse behaviours expressed by the varying-sized 
APs firing within the sympathetic multi-unit neurogram under baseline conditions and 
during periods of physiological stress (103, 104, 106). These complex patterns of AP 
activity — defined broadly as sympathetic communication strategies — are tailored to the 
magnitude and form of stress and employed by the sympathetic nervous system to 
communicate the circulatory adjustments necessary for homeostatic maintenance (106). 
Among APs firing synchronously to form bursts, multiple size-related subpopulations 
exist expressing heterogeneous discharge and recruitment characteristics that contribute 
to fluctuations in burst size and occurrence over time. The firing probability of APs 
active at baseline (i.e., low-threshold APs) varies by size to resemble an inverted ‘U’ 
shaped distribution as medium APs fire in most bursts, while the small and large APs 
discharge less often (74, 101). 
During diverse forms of physiological stress, two key AP patterns elevate total MSNA. 
First, the sympathetic system utilizes a rate-coding strategy which defines the increased 
firing of previously-active AP subpopulations achieved via a greater occurrence of 
synchronized bursts of AP discharge and a greater propensity for multiple firing within 
each burst of activity (79, 110). Because the wavelet approach does not track APs arising 
from single fibres over time, rate-coding from this perspective refers to an increase in the 
firing probability of similarly-sized APs (i.e., clusters) already active at baseline. Second, 
during stress the sympathetic system utilizes a population-coding strategy which 
describes the recruitment of larger and faster-conducting AP clusters that were not active 
at baseline. These strategies appear to be reflex non-specific as they have been observed 
during a host of stressors targeting the chemoreflex (3, 6, 88, 110), baroreflex (6, 74, 99–
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101), and metaboreflex (5) among other forms of physiological stress such as apnea (4, 
69). Fig. 1.2 provides an overview of the varying-sized AP subpopulations contained 
within the filtered neurogram. 
Not all APs previously-active at baseline appear to increase firing rates with 
physiological stress, however. During the hypotensive phase of a sodium nitroprusside 
bolus infusion, Limberg and colleagues (74) found the cluster of the smallest APs 
extracted using the wavelet technique to express a paradoxical reduction in firing 
probability, while medium clusters fired more often and a subpopulation of larger and 
faster-conducting APs were recruited. Studies from laboratories employing high 
impedance electrodes to examine a few active APs provide evidence consistent with this 
phenomenon. In a sample of young and middle-aged healthy individuals, Millar and 
colleagues identified a subpopulation of APs that fired less often during modest LBNP (-
10 mmHg) and moderate rhythmic handgrip exercise (40 % max effort) (57, 85). While 
the different microneurographic techniques preclude direct comparisons between studies, 
these observations suggest that a subpopulation of sympathetic APs, perhaps arising from 
the smallest postganglionic axons, may be inhibited during periods of sympathetic 
arousal such as simulated orthostatic stress or physical exercise. If so, this feature aligns 
with the de-recruitment or reduced firing of low-threshold motor neurons during periods 
of high-threshold neuron activation as observed in decerebrate cats (64). This concept 
remains to be studied directly for postganglionic sympathetic c-fibres. 
The AP cluster latency represents a critical criterion for making inferences regarding 
axonal size within the microneurographic recording field (110). In a similar manner to 
measuring burst latency, AP latency represents the time from the R-wave associated with 
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AP occurrence and the negative peak of the AP waveform (99). According to cable 
theory, axonal size should be proportional to its conduction velocity and AP amplitude 
(91, 121). Importantly, when regressing AP cluster latency against AP cluster size an 
exponential decay relationship emerges consistently for AP data obtained at baseline and 
physiological stress, indicating that larger APs arise from larger axons that express faster 
conduction velocities (6, 69, 100, 110). This evidence argues against the notion that 
larger APs reflect depolarization of axons closer to the microelectrode tip.  
The temporal behaviour of AP discharge represents an additional strategy for modifying 
MSNA. At baseline, Macefield and colleagues (81) reported considerable variation in 
latency of single sympathetic axons, providing additional support for the idea that 
variable synaptic delays exist in the central sympathetic organization. During both 
Valsalva’s Manoeuvre and apnea, all AP clusters express reduced latency (4, 6, 69, 100). 
Based on the observation that AP latency was reduced during isometric handgrip but 
returned to baseline values in the subsequent period of circulatory occlusion suggests that 
the central command mechanism related to perceptual effort may contribute to this 
phenomenon (5). In contrast, severe baroreflex stress in the absence of perceptual stress 
such as that imposed by -80 mmHg LBNP prolongs the latency of all AP clusters (6, 99). 
The mechanisms shaping AP latency also appear chronically modifiable as exposure to 
60-days of head-down bed rest increased the latency of all APs firing at baseline and 
during apneic stress (69).  
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Figure 1.2 Data from a single participant providing an overview of the discharge 
characteristics associated with the varying-sized sympathetic action potential (AP) 
subpopulations. Low-threshold APs are active under baseline conditions and are 
comprised by three fundamental subpopulations small, medium, and large, as highlighted 
on the right (see text for details). During physiological stress such as -80mmHg lower 
body negative pressure (LBNP), some low-threshold APs increase their firing rate. Also, 
a subpopulation of high-threshold larger APs are recruited during physiological stress. 
Each panel illustrates AP discharge over time as a function of their diastolic blood 
pressure (DBP; top) and cluster (left). AP cluster refers to all APs of similar morphology 
and are normalized between conditions to ensure within-participant comparisons (e.g., 
cluster 1 represents the same-sized APs at BSL and LBNP). (Previous page). 
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1.4.1 Baroreflex Control of Muscle Sympathetic Nerve Activity  
As mentioned, pulse-rhythmic input from arterial baroreceptors shapes the bursty 
behaviour of MSNA and contributes to the time-varying outflow of sympathetic 
discharge (33). Arterial baroreflex control of MSNA can be derived by measuring 
baroreflex gain, the strength of the relationship between baroreflex-mediated MSNA 
changes and spontaneous blood pressure oscillations. Sundlöf and Wallin (116) designed 
this strategy to examine baroreflex-mediated alterations in integrated burst probability 
(i.e., baroreflex threshold analysis) and integrated burst amplitude (i.e., baroreflex 
sensitivity analysis) for given changes in blood pressure. Commonly, baroreflex threshold 
analysis involves grouping diastolic blood pressure into bins (e.g., 1 or 2 mmHg bin 
width) and calculating the percentage of heartbeats per diastolic bin that were associated 
with an integrated burst (50, 66, 101). The slope of the linear relationship between burst 
probability and diastolic blood pressure represents baroreflex threshold gain. 
Alternatively, baroreflex sensitivity examines the slope of the linear relationship between 
amplitude of each burst and its corresponding diastolic blood pressure (50).  
Comparison of baroreflex threshold and sensitivity measures by Kienbaum and 
colleagues (66) demonstrated stronger baroreflex threshold than sensitivity slopes in each 
participant during baseline. This finding spurred the baroreflex-gating hypothesis stating 
that the baroreflex gates whether or not a burst will fire but other central neural processes 
influence the size (i.e., AP content) of each burst. This notion aligns with the observation 
that the severity of LBNP was positively related to the change in burst frequency from 
baseline, while no relationship existed with the change in burst amplitude (117). In 
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contrast, some forms of chemoreflex stress preferentially augment burst size over burst 
frequency (82, 111). 
To explain the observations regarding differential baroreflex regulation of burst 
occurrence versus size, Salmanpour and Shoemaker (2012) studied the baroreflex control 
of AP discharge by regressing AP firing probability of each cluster against diastolic 
blood pressure (i.e., baroreflex threshold analysis). During baseline conditions this 
approach revealed that the gain of baroreflex control over AP discharge linearly 
decreases with increasing AP cluster size indicating that the arterial baroreflex strongly 
governs small-to-medium AP discharge but exerts weak control over larger AP cluster 
firing. Thus, the baroreflex strongly governs burst occurrence because it affects medium 
AP firing, which occur in most bursts. Alternatively, burst amplitude is only minimally 
affected by the arterial baroreflex because larger AP clusters express weak slopes and fire 
less often. Also, because burst amplitude represents both the size and number of 
synchronously firing APs (110), Salmanpour and Shoemaker (2012) examined the 
relationship between the number of unique AP clusters per burst and the diastolic blood 
pressure associated with that burst (i.e., baroreflex sensitivity analysis). This method also 
revealed weak slopes, suggesting the baroreflex does not strongly govern within-burst AP 
content (101). Together, the observation that larger AP clusters fire less often, express 
weak baroreflex slopes but contribute more to integrated burst size, and that the 
baroreflex weakly controls the number of AP clusters per burst, results in minimal 
baroreflex control over burst amplitude. Consistent with these data are the repeated 
findings that baroreflex stress (i.e., imposed by LBNP or sodium nitroprusside) weakly 
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recruits subpopulations of larger and faster conducting APs, at least until severe levels of 
baroreflex unloading in some individuals (6, 74, 99).  
1.5 Integrated Rationale 
As illustrated in the discourse above, single- and multi-fibre microneurographic 
recordings have revealed an array of intricate behaviours contained within the 
sympathetic discharge directed towards the circulation supplying skeletal muscle (80, 
106). Fundamentally, the complexity of sympathetic neural emissions stems from the 
heterogenous firing probabilities expressed by sized-related AP subpopulations. Of APs 
synchronized into bursts under baseline conditions (i.e., low-threshold APs), medium 
APs fire in most bursts, whereas the small and large APs fire less often (101, 110). These 
low-threshold APs are critical for communicating with the vasculature and supporting 
homeostasis in humans under baseline conditions. Given that postganglionic emissions 
reflect the central and peripheral organization of the sympathetic system (59), 
heterogenous discharge behaviours among AP subpopulations suggest differential 
regulatory mechanisms. While the arterial baroreflex governs the behaviour of some low-
threshold APs during baseline (101), other neural mechanisms affecting AP patterns 
remain to be investigated.  
To maintain homeostasis during physiological stress the sympathetic system employs two 
key strategies to increase total MSNA. First, the sympathetic system increases the firing 
rate of previously-active APs, then during severe stress, the system recruits a 
subpopulation of latent larger and faster-conducting APs (5, 99). Recently, research 
efforts have been dedicated to understanding the discharge patterns and reflex 
mechanisms governing larger previously-silent (i.e., high-threshold) sympathetic APs (3, 
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4, 6), yet the AP subpopulations expressing heterogenous discharge under baseline 
conditions and augmented firing probabilities during physiological stress have received 
less attention.  
Therefore, the present dissertation proposed the overall objective to investigate the 
behaviour and mechanisms governing the low-threshold (i.e., active at baseline) 
sympathetic AP subpopulations. This dissertation tested the overall hypothesis that 
heterogeneous discharge behaviour exists among varying-sized low-threshold AP 
subpopulations under baseline conditions and during physiological stress, due to differing 
regulation within the sympathetic organization. While each study addresses the overall 
objective and hypothesis in a specific way, the following discourse highlights the logical 
succession of studies that emerged with our observations. 
At the paravertebral ganglia, patterns of divergent and convergent pre- to postganglionic 
innervation amplify distribution and confer complexity to the discharge of varying-sized 
sympathetic c-fibres (42, 84), respectively. In fact, synaptic convergence appears to vary 
by sympathetic postganglionic neuron size in lower animals (93, 94), a feature which 
may produce AP size-related firing characteristics. Therefore, Study One (71) tested the 
hypothesis that the paravertebral ganglia contribute to the discharge behaviour of 
sympathetic APs active at baseline in humans. Two novel findings emerged from this 
study: 1) Trimethaphan infusion produced ordered AP de-recruitment whereby the large 
APs firing with low probability during baseline were abolished first, followed by the 
reduced discharge probability of smaller APs; 2) Although trimethaphan infusion blocked 
integrated bursts of MSNA, we observed the smallest APs to express trimethaphan-
resistance and fire in an asynchronous manner. We interpret these observations to suggest 
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that the ganglia contribute to the heterogeneous discharge patterns among varying-sized 
APs due to differential patterns of ganglionic synaptic input. Also, we hypothesize that 
the trimethaphan-resistant property of smaller APs reflects non-nicotinic mechanisms 
(60), which participate in neurotransmission at the human sympathetic ganglia.  
The primary characterization of MSNA to date focuses on pulse-rhythmic bursts formed 
by the synchronized discharge of varying-sized APs (49, 110). But observations made in 
Study One (71) and studies in lower animals (14, 15) suggest that some sympathetic c-
fibres may express non-burst forming asynchronous discharge, and that the ganglia may 
participate in this behaviour (15). Therefore, Study Two (72) tested the hypothesis that 
synchronous and asynchronous discharge exist among sympathetic APs and the ganglia 
affect AP synchronicity. By studying all APs rather than just those within identified 
bursts, we found that: 1) At baseline, ~30% of total sympathetic AP discharge fired 
asynchronously, between bursts; 2) The probability of asynchronous discharge was 
related inversely to AP cluster size and the asynchronous AP discharge frequency was 
not affected by baroreflex or apneic stress; 3) While the largest asynchronously firing AP 
clusters present at baseline were blocked by trimethaphan infusion, the smaller 
asynchronous APs persisted to fire. We interpret these findings to suggest that the 
fundamental behaviour of MSNA contains between-burst asynchronous AP discharge, 
which accounts for a considerable amount of baseline activity, and the ganglia contribute 
to some, but not all asynchronous AP firing.  
Pulse-rhythmic arterial baroreceptor input synchronizes APs into bursts (33) and of the 
APs organized into these bursts, arterial baroreflex control relates inversely to AP cluster 
size under baseline conditions (101). However, our understanding of baroreflex AP 
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control remains unclear given that Study Two found ~30% of total APs to fire 
asynchronously outside baroreflex-gated bursts at baseline, with the smallest APs 
expressing the greatest proportion of asynchronous discharge (72). Combined with the 
finding that the baroreflex primarily relies on augmenting the firing probability of 
previously-active APs to maintain blood pressure during orthostatic stress (99), these 
observations warrant an investigation into the heterogeneity of baroreflex control over 
AP discharge. Accordingly, Study Three tested the hypothesis that the baroreflex exerts 
the strongest gain over medium-sized APs that fire with high probability under baseline 
conditions, and the change in position and slope of each clusters baroreflex curve 
accompanying orthostatic stress should vary across the distribution of recorded APs. 
Here, by studying all active APs, we found that medium APs expressed the greatest 
baroreflex gain while the smallest and largest clusters expressed lesser gains during 
baseline conditions. On going from baseline to baroreflex stress, the baroreflex gain for 
each AP cluster was modified differently: the medium AP slopes increased, while the 
slopes for the small and large APs present at baseline exhibited a reduction and no 
change, respectively. Also, the larger AP clusters that were silent at baseline but recruited 
during orthostatic stress expressed weak baroreflex gains. From these findings we infer 
that resetting the activity upwards and augmenting the gain of a discrete group of medium 
APs already active at baseline, as well as the recruitment of a non-baroreflex high-
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2 The role of the paravertebral ganglia in human 
sympathetic neural discharge patterns 
Published in The Journal of physiology: 596(18), 4497-4510, 2018. 
2.1 Introduction 
The ganglia determine the extent to which the sympathetic nervous system communicates 
central intentions to the peripheral vasculature supplying skeletal muscle (13). The 
ganglia participate in spatial amplification of efferent sympathetic outflow through 
synaptic divergence of a distribution of primary “strong” synapses (19, 35). Also, 
patterns of pre-to-postganglionic convergent innervation have been observed in rodent 
and amphibian models (41, 52). As the degree of convergence appears to scale with 
neuron size in mammals (39, 40), it would be expected to add greater complexity to the 
temporal and spatial summation of excitatory post-synaptic potentials (EPSP).  
The synchronization of differently-sized action potentials (AP) into bursts of activity 
represents a fundamental characteristic of sympathetic activity, readily observed in 
neurograms of sympathetic nerve activity directed towards the vasculature of skeletal 
muscle (MSNA). Furthermore, multi-unit and single-unit recordings of axonal firing 
patterns within MSNA bursts have revealed additional layers of complexity regarding 
communication strategies contained within the sympathetic neural signal in humans (31, 
47, 51). For instance, under baseline conditions, recruited axons fire with relatively low 
probability [e.g., 21% of cardiac cycles (32)]. In addition, multi-unit AP recordings show 
that as a population, firing probabilities of differently-sized APs (probably not the same 
axon) tend to vary with AP size in an inverted “U” manner, such that the smallest AP 
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clusters and largest AP clusters express low within-burst probabilities whereas 
moderately-sized AP clusters are expressed frequently, with some occurring in every 
burst (28, 45, 54). Furthermore, acute homeostatic challenges (e.g., apneic, metabolic, 
and orthostatic stress) reveal an orderly recruitment strategy where the sympathetic 
system expresses options of increasing the firing probability of already-active APs and, in 
high stress, recruitment of a subpopulation of latent, larger and faster-conducting APs (2, 
43, 54). Further, the timing of a recruited AP may be modified by synaptic delays (11, 
61): a feature which we hypothesize to be mediated in part, by perceptual mechanisms (3, 
26, 44). These ordered patterns of postganglionic AP behaviour and recruitment infer 
heterogeneous regulation of sympathetic neurons. However, the neural sites within reflex 
arcs and/or descending sympathetic pathways that exert influence over these discharge 
patterns remain uncertain. 
Even at the level of the integrated sympathetic signal, the neural circuitry involved in 
MSNA control remains unclear. While the brainstem network forming the arterial 
baroreflex represents perhaps the most thoroughly studied site of sympathetic regulation, 
contributing to the pulse-synchronous “bursty” nature of the signal (53), evidence also 
points towards baroreflex-independent pathways as a source of MSNA patterns, 
especially fluctuations in burst amplitude, which are dependent on AP content (23, 33). 
For example, supra-medullary sites are involved in regulating sympathetic outflow (4, 15, 
25, 48, 57), including the variability in burst size (56). To date, however, few 
investigations have studied the contribution of other, non-baroreflex sites within the 
sympathetic system, to patterns of sympathetic discharge, such as spinal (55) or 
ganglionic mechanisms.  
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This study tested the hypothesis that the paravertebral ganglia contribute to ordered 
patterns of sympathetic AP discharge at baseline in humans. To address this hypothesis, 
we examined the impact of paravertebral ganglionic blockade (via intravenous 
trimethaphan camsylate) on multifibre recordings with microneurography at the peroneal 
nerve in female participants.  
2.2 Methods 
2.2.1 Ethical Approval 
All procedures were approved by the Mayo Clinic Institutional Review Board (No. 09-
008548) and the study conformed to the standards set by the Declaration of Helsinki, 
except for registration in a database. All participants provided written, informed consent 
after receiving verbal and written instructions outlining the experimental protocol. 
2.2.2 Participants 
This study evaluated data from seven healthy females (37 ± 5 years, 165 ± 2 cm, 60 ± 4 
kg, 22 ± 1 kg/m2, 25 ± 3 % body fat). On a separate day prior to the testing session, 
participants performed health screening to determine that all fit study inclusion/exclusion 
criteria: non-smoker, systolic blood pressure (BP) <150 mmHg, diastolic BP <95 mmHg, 
body mass index <30 kg/m2, and no history of diabetes or cardiovascular diseases. All 
participants provided a negative pregnancy test result within 48 h. Pre-menopausal 
women (n = 5) were tested in the early follicular stage of the menstrual cycle (days 2-6 of 
menses) or the placebo phase for young women on oral contraceptives (n = 2, participant 
identifiers TM59 and TM63, both taking levonorgestrel and ethinyl estradiol). No other 
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participants were taking medications. Two participants were post-menopausal (n = 2, 
participant identifiers TM32 and TM50, 7 and 6 years since last menses, respectively).  
2.2.3 Experimental Procedures 
Participants arrived at the laboratory after an overnight fast and refraining from heavy 
exercise, caffeine, and alcohol for 24 h before the study. Participants assumed the supine 
position for instrumentation and data collection. After local anesthetic with 2% lidocaine, 
a 5-cm 20-gauge arterial catheter was placed in the brachial artery of the non-dominant 
arm, using aseptic technique. The catheter was connected to a pressure transducer, 
positioned at heart level to record continuous arterial BP. A 3-lead electrocardiogram 
(ECG) recorded continuous heart rate (HR). Research personnel placed an intravenous 
catheter in the contralateral arm for drug infusion. 
2.2.4 Experimental Design 
Data were collected during baseline and the trimethaphan camsylate infusion (1-7 
mg/min; Cambridge Laboratories, Wallsend, United Kingdom). Trimethaphan infusion 
rate was adjusted over time, though this varied across participants. During the 
trimethaphan infusion, once cessation of integrated MSNA burst activity occurred, 
participants were instructed to perform a 20 s Valsalva’s Manoeuvre with an expiratory 
mouth pressure of 40 mmHg. After discontinuation of the study and de-instrumentation, 
subjects remained in the Clinical Research Unit for ≥ 2 hours for observation.  
Data analysis was conducted for four study conditions: 1) 5-min baseline (309 ± 28 s), 2) 
minute-by-minute of the trimethaphan infusion where integrated sympathetic bursts were 
visible and AP analysis could be performed [note that the last “minute” was 89 ± 17 s to 
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provide a suitable number of bursts for analysis], 3) two minutes (120 ± 0 s) of the 
trimethaphan infusion where sympathetic bursts were not visible, and 4) a Valsalva’s 
Manoeuvre performed during the trimethaphan infusion where sympathetic bursts were 
not visible (23 ± 7 s).  
2.2.5 Experimental Measures and Analysis 
Efferent multiunit MSNA was measured from postganglionic C-fibres in the peroneal 
nerve by microneurography (14) as detailed recently (26). Integrated bursts of MSNA 
were analyzed if they were pulse-synchronous, had a signal-to-noise ratio of at least 2:1 
relative to the previous period of neural silence, and expressed characteristic rising and 
falling slopes. MSNA bursts were inspected for consistent amplitude to rule out shifts in 
microelectrode position.  
At the integrated level, sympathetic activity was quantified as burst frequency 
(bursts/min) and burst incidence (bursts/100 heartbeats). Burst amplitude (AU) was 
measured in volts and normalized to the max burst amplitude at baseline, which was 
given a value of 100. Total MSNA (AU/min) was measured as the product of burst 
frequency and amplitude. Sympathetic burst latency was measured as the mean time 
interval (s) from the preceding ECG R-wave, to the peak of the corresponding MSNA 
burst in the integrated neurogram (12).  
Postganglionic sympathetic APs were detected and extracted from the filtered raw 
MSNA signal using a continuous wavelet transform, which has been described in detail 
previously (42). At baseline and during trimethaphan infusion where integrated bursts 
were visible, APs were only extracted if they occurred within an integrated burst (i.e., 
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0.8s around the peak of the burst). Alternatively, during trimethaphan infusion where 
integrated bursts were no longer visible, any AP that occurred was extracted. With both 
techniques, extracted APs were ordered based on peak-to-peak amplitude, and histogram 
analysis was performed to separate APs into amplitude-based clusters. Cluster bin widths 
for baseline data were automatically defined based on Scott’s rule which balanced bin 
width, data bias and variance to minimize the integrated mean square error (46). Thus, 
the number of total clusters at baseline varied by participant. AP data collected during the 
different periods of the trimethaphan infusion (i.e., MSNA bursting period, non-bursting 
period, and Valsalva’s Manoeuvre) were normalized to baseline for each participant to 
ensure that bin width, maximum bin centre, and the total number of bins would be 
identical across conditions. APs that were not detected during trimethaphan were 
considered de-recruited from baseline. The signal-to-noise ratio was determined as the 
amplitude of the negative peak of the mean AP over the standard deviation of the 
background noise. Based on our previous simulations, the signal-to-noise ratio of the 
multi-unit AP signal obtained at baseline (4.2 ± 0.7) and during trimethaphan (4.2 ± 0.5) 
was expected to produce a correct detection rate of > 90% and a false positive rate of 
<3% (42).  
AP indices included AP frequency (APs/minute), incidence (APs/100 beats), and the 
mean AP content per integrated burst. Also, the number of total clusters detected and the 
number of active clusters per integrated burst were assessed. AP latency was determined 
as the time delay from the R-wave of the preceding cardiac cycle to the negative peak of 
the AP (44). AP cluster latency was determined as the mean latency of all APs within a 
cluster. AP cluster firing probability distributions were constructed to evaluate the firing 
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probability of each sympathetic AP cluster at baseline and the final minute of bursting 
activity during the trimethaphan infusion. To do so, we divided the number of times an 
AP cluster fired by the total number of bursts that occurred in a given condition, 
multiplied by 100%. A probability of 100% indicates that the cluster fired once in every 
integrated burst, whereas a probability of less than, or greater than, 100% indicates that 
the cluster was not active in every burst, or occasionally fired more than once per burst, 
respectively.  
HR and BP were collected at 1,000 Hz. The mean values for HR and mean arterial 
pressure (MAP) were calculated for all conditions. All signals were sampled using 
PowerLab (ADInstruments; Castle Hill, New South Wales, Australia) and stored on a 
computer for subsequent analysis. Researchers were not blinded during analysis.  
2.2.6 Statistical Analysis 
This study tested the hypothesis that the ganglia contribute to patterns of postganglionic 
sympathetic AP discharge at baseline in humans. All data are presented as mean ± SD. 
Due to the inter-individual variability in magnitude and time course of the nicotinic 
blockade, minute-by-minute changes in all sympathetic indices with trimethaphan 
infusion were not evaluated statistically. Accordingly, paired sample t-tests were 
employed to assess differences between: 1) baseline versus the last minute of bursting 
activity during the trimethaphan infusion, and 2) the non-bursting period of the 
trimethaphan infusion versus the responses to Valsalva’s Manoeuvre. For AP clusters 
expressing trimethaphan-resistance, a repeated-measures analysis of variance (RM 
ANOVA) assessed changes in AP incidence across baseline, the last minute of the 
trimethaphan infusion with visible bursts, and the period of the trimethaphan infusion 
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without visible bursts. Linear regression was performed to assess the relationship 
between normalized integrated burst amplitude and AP content per burst. Statistical 
analysis was performed using SPSS (v 23, SPSS Inc., Chicago, IL). Tests were two tailed 
with α = 0.05. Each unique symbol represents the same participant’s data across figures 
depicting individual data. 
2.3 Results 
Fig. 2.1 illustrates one participant’s response to trimethaphan infusion, particularly the 
reductions in integrated bursting activity (Fig. 2.1 A1) and the discharge patterns of 
sympathetic AP clusters during drug infusion (Fig. 2.1 A2). These results compare 
baseline to the last minute of visible bursting activity that was suitable for AP analysis 
during the trimethaphan infusion, unless specified otherwise. The mean time from 
infusion start to burst cessation was 523 ± 242 s. At this time, the infusion rate was 2 ± 1 
mg/min. Trimethaphan infusion was associated with an increase in HR (baseline versus 
final minute of trimethaphan condition with MSNA bursts: 57 ± 11 to 66 ± 12 bpm, P < 
0.01) and a reduction in MAP (97 ± 7 to 90 ± 7 mmHg, P < 0.01) compared to baseline 
(Fig. 2.2). Relative to baseline, trimethaphan elicited a progressive reduction in total 
sympathetic outflow (833 ± 458 to 157 ± 120 AU/min, P < 0.01), characterized by fewer 
integrated bursts (burst frequency: 17 ± 9 to 5 ± 4 bursts/min, P = 0.01; burst incidence: 
30 ±14 to 9 ±8 bursts/100beats, P < 0.01) with decaying amplitude (49 ± 3 to 31 ± 3 AU, 
P < 0.01) (Fig. 2.3). Underlying trimethaphan-mediated attenuations in the integrated 
MSNA signal were reductions in AP frequency (104 ± 65 to 17 ± 17 AP/min, P = 0.01) 
and incidence (186 ± 101 to 29 ± 31 AP/100beats, P < 0.01) as well as attenuated AP 
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content per integrated burst (7 ± 2 to 3 ± 1 AP/burst, P < 0.01) (Fig. 2.4). When detected 
APs were binned according to peak-to-peak amplitude, the total number of active AP 
clusters was reduced with trimethaphan (14 ± 3 to 8 ± 2, P < 0.01), resulting in fewer 
unique clusters firing per burst (4 ± 1 to 3 ± 1 clusters/burst, P < 0.01) (Fig. 2.4). 
Trimethaphan infusion did not affect the latency of MSNA bursts (1.25 ± 0.05 to 1.22 ± 
0.05) or APs (1.18 ± 0.06 to 1.16 ± 0.07 s) (both P > 0.12). 
Closer analysis of the within-burst AP cluster firing patterns revealed a distribution of 
firing probabilities that scaled to AP cluster size in an inverted “U” manner. At baseline, 
moderately-sized clusters fired with high probability (i.e., approximately every burst), 
whereas the smallest AP clusters and largest AP clusters expressed low within-burst 
probabilities across all participants. In the last minute of visible bursting activity during 
the trimethaphan infusion, participants demonstrated a reduction in the firing probability 
of the majority of AP clusters with the largest AP clusters (range: 4 to 10 largest clusters) 
ceasing to fire, moderately-sized cluster firing displaying moderate declines in 
probability, and generally no change in the activity of smaller clusters. Firing probability 
distributions for each participant (Fig. 2.5A) enable visualization of the between-subject 
variability in active cluster number and the extent of large cluster de-recruitment with 
trimethaphan, whereas, the group averaged normalized distributions (Fig. 2.5B) show a 
similar pattern of reduced cluster firing probability with trimethaphan but allow statistical 
comparisons between baseline and trimethaphan. 
At baseline, AP cluster latency decreased as a function of normalized cluster number 
(i.e., as peak-to-peak AP cluster amplitude increased) (R2 = 0.67, P < 0.01). Because 
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trimethaphan abolished the firing of the largest clusters, the AP cluster latency-size 
relationship was examined for the entire condition (i.e., from infusion start until the last 
minute of visible bursting activity) and was not restricted to the final minute of bursting 
activity. Here, the same general pattern was observed, but did not reach significance (R2 
= 0.28, P = 0.11). The mean AP cluster latency-size responses were fitted using an 
exponential decay function (Fig. 2.6). These relationships support the concept that AP 
cluster size scaled to the diameter of sympathetic C-fibres within the recording field of 
the micro-electrode.  
At baseline, linear regression indicated moderate-to-strong relationships between relative 
integrated burst size and the number of APs per burst (y = 0.14 ± 0.05x – 0.37 ± 0.55, r2 = 
0.57 ± 0.17, all P < 0.01), normalized integrated burst amplitude and AP clusters per 
burst (y = 0.05 ± 0.02x + 1.64 ± 0.31, r2 = 0.37 ± 0.21, all P < 0.01), and the number of 
AP clusters per burst and the number of APs per burst (y = 0.33 ± 0.05x + 1.78 ± 0.13, r2 
= 0.60 ± 0.13, all P < 0.01). In the last minute of visible bursting activity during the 
trimethaphan infusion, the same fundamental relationships were observed, though these 
were not significant in all participants (integrated burst size vs. the number of APs per 
burst: y = 0.12 ± 0.08x + 0.02 ± 3.3, r2 = 0.30 ± 0.25, P < 0.05 in n = 3 of 7 participants, 
normalized integrated burst amplitude vs. AP clusters per burst: y = 0.04 ± 0.05x + 1.65 ± 
2.0, r2 = 0.19 ± 0.16, P < 0.05 in n = 2 of 7 participants, and the number of AP clusters 
per burst vs. the number of APs per burst: y = 0.36 ± 0.25x + 1.28 ± 0.62, r2 = 0.56 ± 




During the period of the trimethaphan infusion where integrated bursts were no longer 
visible (120 ± 0 s, 80 ± 6 bpm, MAP: 87 ± 12 mmHg), we observed the discharge of a 
population of trimethaphan-resistant APs. In all seven individuals, these APs were the 
smallest 6 ± 2 sympathetic AP clusters (range: 4 – 8 AP clusters) present at baseline, 
firing in an asynchronous pattern (i.e., visual inspection showed no apparent baroreflex-
mediated pulse rhythmicity) with a frequency of 38 ± 32 AP/min (49 ± 41 AP/100beats) 
(Figure 1 B1 and B2). Compared to baseline (118 ± 61 APs/100beats), trimethaphan-
resistant clusters (i.e., not clusters de-recruited by trimethaphan), demonstrated reduced 
incidence in the last minute of visible bursts during trimethaphan infusion (26 ± 24 
APs/100beats, simple-effects paired t-test: P < 0.01) as well as during the period of the 
trimethaphan infusion without visible bursts (49 ± 41 APs/100beats, simple-effects paired 
t-test: P: < 0.05; RM ANOVA: P < 0.05). There were no differences in the incidence of 
trimethaphan resistant clusters between the final minute of visible bursts during 
trimethaphan and the period of the trimethaphan without visible bursts (simple-effects 
paired t-test: P > 0.3).  
While trimethaphan infusion continued, research personnel instructed participants to 
perform a Valsalva’s Manoeuvre. Valsalva’s Manoeuvre (28 ± 9 and 24 ± 7 mmHg 
reduction in MAP and PP, respectively, from baseline to phase II, both P < 0.01) failed to 
elicit integrated MSNA bursts in six of seven participants. When examining the data from 
the six individuals with absent MSNA responses to Valsalva’s Manoeuvre only, 
compared to the period of the trimethaphan infusion where trimethaphan-resistant APs 
were observed, but integrated bursts were not visible (38 ± 32 AP/min; 49 ± 41 
APs/100beats), the Valsalva’s Manoeuvre did not increase the firing frequency of 
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trimethaphan-resistant APs (49 ± 32 AP/min, 60 ± 42 AP/100beats; both P > 0.30, both d 















Figure 2.1 Representative recordings of heart rate (HR), blood pressure (BP), and the 
integrated muscle sympathetic nerve activity (MSNA) neurogram from one individual. 
Data were collected during the trimethaphan infusion where integrated MSNA bursts 
were detected (A1) and during the trimethaphan infusion where integrated MSNA bursts 
were no longer visible (B1). The associated pattern of action potential (AP) activity 
during the trimethaphan infusion where integrated MSNA bursts were detected (A2) and 
during the trimethaphan infusion where integrated MSNA bursts were no longer visible 
(B2) is illustrated. A2: AP occurrence within each burst as a function of their cluster 
(illustrated along the left). Cluster refers to all APs of similar morphology. B2: Because 
no bursts were detected, all AP activity was extracted and presented as a function of their 














Figure 2.2 Systolic (SBP; A), diastolic (DBP; B), mean arterial pressure (MAP; C), and 
heart rate (HR; D) at baseline (BSL) and during each minute of the trimethaphan infusion 
where integrated sympathetic bursts were visible. Minute-by-minute data are presented 
by line graphs with each unique symbol representing the same participant’s data across 
figures depicting individual data. Mean ± SD for BSL and the last minute of detectable 
integrated sympathetic bursting activity during the trimethaphan infusion (Last min) are 
represented by half-filled circles and error bars.  *, indicates significantly different from 














Figure 2.3 Integrated muscle sympathetic nerve activity (MSNA) burst frequency (BF; 
A), burst incidence (BI; B), normalized burst amplitude (C), and total activity (D) at 
baseline (BSL) and during each minute of the trimethaphan infusion where integrated 
sympathetic bursts were visible. Minute-by-minute data are presented by line graphs with 
each unique symbol representing the same participant’s data across figures depicting 
individual data. Mean ± SD for baseline and the last minute of detectable integrated 
sympathetic bursting activity during the trimethaphan infusion (Last min) are represented 
















Figure 2.4 Sympathetic action potential (AP) frequency (A), AP incidence (B), APs per 
burst (C), AP clusters per burst (D), and total AP clusters (E) at baseline (BSL) and 
during each minute of the trimethaphan infusion during the period where integrated 
sympathetic bursts were visible. Minute-by-minute data are presented by line graphs with 
each unique symbol representing the same participant’s data across figures depicting 
individual data. Mean ± SD for baseline and the last minute of detectable integrated 
sympathetic bursting activity during the trimethaphan infusion (Last min) are represented 























Figure 2.5 Sympathetic action potential (AP) cluster probability distributions for each 
participant at baseline (BSL) and the last minute of visible integrated sympathetic 
bursting activity during the trimethaphan infusion (TM Last Min) (A). Group averaged 
sympathetic AP probability distributions for BSL and TM Last Min with AP clusters 
normalized to the largest cluster at baseline (B). For both individual and group averaged 
figures a probability of 100% indicates that the cluster fired once in every integrated 
burst, whereas a probability of less than or greater than 100% indicates that the cluster 
occasionally fired more than once per burst or was not active in every burst, respectively. 














Figure 2.6 Action potential (AP) cluster latency as a function of AP cluster size at 
baseline (BSL) and during the entire trimethaphan infusion. The decrease in cluster 
latency as a function of amplitude was fit with an exponential decay function. Data 












Figure 2.7 The number of sympathetic action potentials (AP) per burst as a function of 
relative integrated burst amplitude (normalized to the largest burst at baseline and during 
the trimethaphan infusion) at baseline (A1) and the last minute of detectable integrated 
sympathetic bursting activity during the trimethaphan infusion (A2). The number of 
unique sympathetic AP clusters per burst as a function of relative integrated burst 
amplitude at baseline (B1) and the last minute of detectable integrated sympathetic 
bursting activity during the trimethaphan infusion (B2). The number of unique AP 
clusters per sympathetic burst as a function of the number of APs per burst at baseline 
(C1) and the last minute of detectable integrated sympathetic bursting activity during the 





The current study provides new evidence regarding the role of the paravertebral ganglia 
in the emission patterns of sympathetic postganglionic nerves directed towards the 
skeletal muscle vasculature. First, we demonstrate that blockade of nicotinic receptors at 
the ganglia elicited an ordered pattern of AP de-recruitment beginning with larger APs 
that fire with lower probability under baseline conditions, followed by the progressive 
decreased probability of smaller APs. Second, following trimethaphan-mediated 
cessation of integrated MSNA bursts, small AP clusters persisted to fire in an 
asynchronous pattern. Also, Valsalva’s Manoeuvre did not increase the firing rate of 
these persistent AP clusters, or elicit recruitment of larger APs that had previously been 
inhibited by trimethaphan. We interpret these observations to suggest: 1) the 
paravertebral ganglia contribute to the heterogeneity in the firing probabilities of 
differently-sized postganglionic sympathetic APs active under baseline conditions, and 2) 
the presence of non-synchronized APs that express resistance to blockade with 
trimethaphan. 
Variations in integrated burst amplitude reflect the number and size of APs synchronized 
to fire at about the same time (37, 43). Varying sized APs express a heterogeneity of 
firing probabilities, such that, compared to moderately-sized APs, larger and smaller APs 
contribute to considerably fewer bursts, while a subpopulation of even larger APs are 
recruited during severe stress (45, 54). Focusing on baseline data only, ganglionic 
blockade in the current study produced an ordered pattern of de-recruitment where larger 
APs were inhibited, reducing burst size, followed by blockade of most small AP clusters, 
rendering integrated bursts from being detected. As these data were collected as part of a 
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larger study, waiting for metabolism of trimethaphan and subsequent return of MSNA 
signal was not possible. Therefore, we cannot rule out the possibility that reductions in 
burst size and AP cluster firing as well as the cessation of bursts following blockade were 
attributed to changes in microelectrode position. However, this is unlikely given the 
observation that small AP clusters were present through the entire study and no changes 
in background signal intensity were observed.  
Whereas trimethaphan exerted early effects on larger AP clusters, our previous studies 
suggest that these clusters must express a higher threshold for recruitment (54). Also, 
based on replicated evidence that larger AP clusters express faster conduction velocity 
(26, 43) we expect that larger AP clusters reflect neurons with larger axons. Together, 
these observations indicate that the larger AP clusters express a higher threshold for 
recruitment and also a higher sensitivity for de-recruitment through a post-junctional 
nicotinic mechanism. These data indicate that the ganglia participate in the recruitment 
probability of larger AP clusters. Furthermore, the observation that medium-sized APs 
exhibited moderate reductions in firing probability but were still active in the final minute 
of MSNA bursting during trimethaphan infusion suggests that the ganglia express some 
differential organization for postganglionic recruitment by neuron size. 
We speculate that this pattern of recruitment and de-recruitment may reflect a scaling of 
preganglionic synaptic input strength at the ganglia. However, the neural mechanisms 
mediating such a preganglionic effect are not known. To our knowledge, beyond the 
investigations using ganglionic blockade as a model of the circulation under negligible 
autonomic control (21, 34) or delineating the origins of the integrated sympathetic signal 
(10), no previous study has examined the role of the ganglia in human sympathetic AP 
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discharge. While earlier studies in animals may provide some insight to the mechanisms 
(e.g., ganglionic convergence) contributing to the present observations, the focus on 
compound APs or single-unit recordings in these investigations (5, 17, 22, 38, 41, 52) 
prevent direct comparisons with the current observations. Interestingly, compared to 
moderately-sized APs that express strong baroreflex modulation, larger APs are weakly 
associated with fluctuations in diastolic BP, suggesting that additional sites of control 
beyond the arterial baroreflex participate in the regulation of the larger, low probability 
APs (45). Similar conclusions have been drawn based on the observation that burst 
occurrence, but not size, was related to diastolic BP in humans (23), causing this latter 
group, and others (33) to speculate on sites outside of the baroreflex pathways that affect 
burst size (analogous to large AP cluster recruitment). Consistent with this idea, both 
magnetic resonance imaging and electroencephalographic studies suggest the 
involvement of neural regions beyond the baroreflex brainstem nuclei in the regulation of 
MSNA (15, 24, 27, 56). In this conjecture, the strength of preganglionic inputs to 
postganglionic neurons possessing larger diameter axons, would reflect a subpopulation 
of descending neural signals from higher cortical sites that are not under direct baroreflex 
regulation.  
The second major observation of the current study was a population of smaller AP 
clusters that persisted to fire in an asynchronous manner, without consistent baroreflex 
rhythmicity, following blockade of nicotinic receptors. To our knowledge, this 
phenomenon has not been reported previously in humans. While these APs may not have 
been sympathetic, this is unlikely as they exhibited similar morphological characteristics 
to the smaller AP clusters that were synchronized to fire within bursts at baseline and 
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during the trimethaphan infusion when integrated bursts were visible. This observation 
also suggests that these clusters did not represent a new population of APs recruited 
following trimethaphan. Also, an incomplete ganglionic blockade likely did not produce 
these APs as, in six of seven individuals, Valsalva’s Manoeuvre performed during the 
non-bursting period of trimethaphan infusion failed to elicit the recruitment of larger AP 
clusters or integrated bursts (44). From these data, we surmise that they represent 
spontaneous firing of postganglionic axons that normally receive cardiac entrainment via 
descending baroreflex inputs and/or are controlled by non-nicotinic synaptic mechanisms 
at the human paravertebral ganglia. Previous studies have documented spontaneous 
neuronal activity within the medullary sites governing sympathetic discharge (9) and 
while this evidence raises the possibility of spontaneous postganglionic spiking, this idea 
has not been tested. Alternatively, detailed studies in feline and rodent models showed 
persistent postganglionic activity during nicotinic blockade, illustrating the contribution 
of non-nicotinic mechanisms to ganglionic signaling (16, 20, 60). Also, ganglionic 
exposure to muscarinic agonists appears to enhance postganglionic nerve activity across 
several studies (7, 60). Janig et al. (1983) further showed that chemoreflex-induced 
discharge was evident in some, but not all postganglionic neurons during combined 
nicotinic and muscarinic (atropine) blockade. In the bullfrog, peptide neurotransmitters 
(including substance P and a peptide resembling luteinizing hormone releasing hormone) 
contribute to postganglionic EPSPs (18). Thus, the most direct explanation of the 
trimethaphan resistant AP clusters in the current observations is that they represent a 
population of neurons with non-nicotinic synaptic mechanisms.  
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The purpose of non-nicotinic ganglionic neurotransmission remains unclear. This feature 
does highlight the complex nature of sympathetic neuronal recruitment. Interestingly, 
repetitive preganglionic nerve stimulation exposes two phases of postganglionic activity 
in vertebrates: These phases are a rapid onset, high frequency discharge mediated by 
nicotinic receptor actions, and a delayed, low frequency firing pattern evoked by 
muscarinic and peptidergic mechanisms (18, 20, 60). The purpose and mechanism(s) 
supporting the trimethaphan-resistance of the smallest AP clusters remains unknown, 
although the observation may be consistent with the conjecture that the ganglia also 
participate in axonal size-related recruitment patterns. It is noted, however, that 
baroreflex unloading via mild (36) and moderate-to-severe lower body suction (3, 43), or 
sodium nitroprusside infusion (28), result in a paradoxical decrease in the firing of some 
APs including smaller clusters, supporting the notion that complex mechanisms may 
regulate small AP patterns. 
An additional explanation for the trimethaphan-resistant AP clusters is that they do not 
represent sympathetic C-fibre spiking. We believe this scenario is improbable for three 
reasons. First, they likely were not produced by sensory axons sensitive to metabolite 
accumulation, stretch, or pain because participants remained still, abstained from exercise 
24 hours prior to testing, and did not report any discomfort throughout the protocol. 
Second, trimethaphan-resistant APs were unlikely to represent Type I/II proprioceptive 
fibre activity, as the myelination of these nerves produces wider APs with prominent 
positive-going depolarization (29, 59), which are distinct from the sympathetic C-fibre 
APs detected by the wavelet model used here (42). Third, we do not suspect that these 
APs represent false positive detections by the wavelet de-noising method because the 
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signal-to-noise ratio for these APs in the trimethaphan period was 4.2 ± 0.7, a high level 
that produces a false detection rate of < 3 % (42). 
Some methodological considerations exist for the present study. First, this study did not 
employ a randomized, placebo control arm alongside the trimethaphan condition. 
However, in healthy individuals under normal conditions of supine rest, complete 
abolishment of MSNA bursts during protracted periods of falling BP would be highly 
unlikely. Second, this investigation only studied pre- and post-menopausal females. Both 
sex and female reproductive hormones are known to affect resting sympathetic outflow as 
well as total MSNA responses to diverse forms of physiological stress (49, 58). However, 
these recruitment strategies appear to be fundamental properties of the human 
sympathetic nervous system (31, 47) that are simply modified by sex hormones, age 
and/or health status (1, 30). Consistent with this notion, the two post-menopausal 
participants (participant identifiers TM32 and TM50) exhibited greater baseline MSNA 
(due to a burst incidence mechanism rather than the AP content per burst) than pre-
menopausal females (TM32, TM50 vs. pre-menopausal mean ± SD: 44, 46 vs. 24 ± 12 
bursts/100beats; 245, 339 vs. 144 ± 80 AP/100beats; 6, 8 vs. 6 ± 2 AP/burst). Despite the 
larger effect of trimethaphan on MSNA burst incidence in post-menopausal females 
versus pre-menopausal counterparts (D 39, D37 vs. D 15 ± 3 bursts/100 beats, D 231, D 
319 vs. D110 ±  51 AP/100beats, D 3, D 5 vs. D 3 ± 1 APs/burst), the ordered pattern of 
trimethaphan-mediated AP de-recruitment was consistent between groups (Fig. 2.5A). 
Third, Valsalva’s Manoeuvre was used to test adequacy of the blockade based clinically 
on heart and BP responses. We recognize that additional manoeuvres before blockade 
would have enabled a prospective analysis of reflex AP recruitment as well. Nonetheless, 
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Valsalva’s Manoeuvre produces a robust AP recruitment stimulus under baseline 
conditions in healthy individuals (44, 50) such that the lack of any recruitment post 
blockade indicates a severe impairment of the ganglionic sympathetic transmission.  
2.4.1 Conclusion 
The current study provides new evidence regarding the role of the paravertebral ganglia 
in human MSNA regulation. Specifically, the organization of the ganglia may contribute, 
in part, to the distribution of firing probabilities exhibited by differently-sized APs at rest 
and the recruitment of previously silent, larger and faster-conducting sympathetic 
neurons during homeostatic stress. Interestingly, our observations also suggest that a 
population of postganglionic neurons with non-nicotinic synaptic mechanisms may exist 
within the human sympathetic nervous system. These findings offer new information 
regarding the neural sites which regulate sympathetic emission patterns fundamental to 
the maintenance of homeostasis and may contribute to chronic adaptations in sympathetic 
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3 Asynchronous action potential discharge in human 
muscle sympathetic nerve activity 
Published online ahead of print in Am J Physiol Heart Circ Physiol. 
 doi: 10.1152/ajpheart.00258.2019  
3.1 Introduction 
The sympathetic nervous system achieves homeostatic adjustments to physiological 
stress by eliciting coordinated circulatory responses that are tailored to the magnitude and 
form of that stress (31). Microneurographic studies of action potentials (AP) emanating 
from postganglionic sympathetic c-fibres directed towards the muscle vasculature have 
revealed many fundamental neural patterns for circulatory control (26, 37). The primary 
characterization of muscle sympathetic nerve activity (MSNA) focuses on pulse-rhythmic 
bursts formed by the synchronized discharge of varying-sized APs entrained to the 
cardiac cycle by the arterial baroreflex (9, 16, 38). Among APs synchronized into bursts, 
multiple size-related subpopulations exist, expressing non-uniform patterns of discharge 
and recruitment that generate the variability in MSNA burst size and occurrence over 
time (23, 37).  
However, studies in humans (24, 34) and lower mammals (10, 19, 22) suggest that 
sympathetic c-fibres may express non-burst forming asynchronous discharge. 
Specifically, in healthy humans, we identified a subpopulation of smaller sympathetic 
APs active under baseline conditions that persisted to fire when trimethaphan had 
abolished integrated bursts. These persistent APs exhibited weak cardiac-rhythmicity, 
producing asynchronous discharge (24). In anesthetized cats, both reflex physiological 
stress (22) and electrical stimulation of upstream nerves (e.g., hypothalamic or 
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preganglionic) (11, 19) produced a rapid burst of synchronized postganglionic nerve 
activity followed by asynchronous neural discharge. Interestingly, the initial burst of 
synchronous APs was abolished by nicotinic blockade, whereas the asynchronously firing 
APs were often blocked by muscarinic antagonists (10, 11, 19, 22), suggesting that non-
nicotinic ganglionic mechanisms contribute to asynchronous behaviour. While the 
abovementioned evidence points towards asynchronous sympathetic nerve discharge, this 
behavior has remained unexplored in humans due to a methodological approach of signal 
integration (17) and/or the focus on single- or multi-unit AP activity that occurs within 
bursts (36). Studying APs that fire at approximately the same time to form bursts as well 
as the APs that express asynchronous behaviour (observed between bursts) in humans 
will improve our understanding of sympathetic neural messaging directed towards the 
circulation.  
Therefore, the present study tested the hypothesis that synchronous and asynchronous 
discharge (i.e., APs firing within and between bursts, respectively) exist among human 
muscle sympathetic APs, and that the ganglia affect synchronicity within the sympathetic 
nervous system. Experiment One quantified AP synchronicity at baseline (BSL) and 
during both baroreflex and apneic stress in eight healthy males and females. Experiment 
Two examined the impact of nicotinic blockade at the paravertebral ganglia (via 





3.2.1 Ethical Approval 
All procedures were approved by the research ethics boards at the University of Western 
Ontario (No. 108026) and Mayo Clinic (No. 09-008548). The study conforms to the 
Declaration of Helsinki, except for registration in a database. Participants provided 
informed written consent following oral and written explanation of the experimental 
procedures and measures. 
3.2.2 Participants 
Experiment One tested eight healthy individuals (n = 4 females, 26 ± 3 years, 170 ± 7 cm, 
69 ± 13 kg), while Experiment Two tested seven healthy females (37 ±	5 years, 165 ±	2 
cm, 60 ±	4 kg). Prior to the testing session the participants performed health screening to 
ensure they met the inclusion/exclusion criteria: non-smoker and no prior diagnosis of 
cardiovascular disease, diabetes, hypertension, or neurological disorder. Experiment One 
did not control for oral contraceptive use or stage of menstrual cycle at time of testing. As 
reported previously (24), n = 5 females in Experiment Two were pre-menopausal and 
tested during the early follicular stage or placebo stage for oral contraceptive users (n = 2, 
both taking levonorgestrel and ethinyl estradiol). Participants were not on any other 
medications. Two female participants in Experiment Two were post-menopausal (6 and 7 
years since last menses).  
3.2.3 Experimental Procedures 
Participants in Experiment One arrived at the Laboratory for Brain and Heart Health at 
the University of Western Ontario for testing after a 4-hour fast and abstaining from 
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vigorous exercise, alcohol, and caffeine for 12-hours prior to the study. Following 
measurement of height and weight, participants assumed the supine position for 
instrumentation and data collection. Participants were sealed in a lower body negative 
pressure (LBNP) chamber distal to the iliac crest. LBNP chamber pressure was measured 
with a pressure sensor (MLT0670, ADInstruments; Castle Hill, New South Wales, 
Australia) calibrated with a manual sphygmomanometer. A strain gauge (Model 1132 
Pneumotrace II, UFI, Morro Bay, CA) enabled investigators to discriminate end-
expiratory apnea (APN) from spontaneous breathing. Continuous arterial blood pressure 
(BP) was measured via finger photoplethysmography and the Modelflow algorithm (41) 
was used to obtain brachial BP, stroke volume, and cardiac output (Finometer; Finapres 
Medical Systems, Amsterdam, The Netherlands). Heart rate (HR) was quantified using a 
three-lead electrocardiogram (ECG). Participants were familiarized with -40 mmHg 
LBNP and at least one APN prior to data collection. Data collection began following at 
least 30-min in the supine position. Procedures for Experiment Two, performed in the 
Human Integrative Physiology Laboratory at Mayo Clinic (Rochester, MN), have been 
described previously (24). 
3.2.4 Experimental Design 
Experiment One data were collected during: at least 5-min BSL, 3-5 minutes of -10 
mmHg LBNP, 3-5 minutes of -40 mmHg LBNP, and APN. Experimental interventions 
were performed in a randomized order, though -10 mmHg was always performed before -
40 mmHg. Bouts of LBNP and the APN were followed by at least 3-min with the lower 
body chamber at ambient pressure prior to the next experimental intervention. Data 
81 
 
analysis was performed on 190 ± 36 s of BSL, 116 ± 33 s of -10 mmHg LBNP, 109 ± 23 
s of -40 mmHg LBNP, and 30 ± 7 s of APN. 
Experiment Two data were collected during BSL and a trimethaphan camsylate infusion 
(1–7 mg/min; Cambridge Laboratories, Wallsend, UK). These data were obtained 
through a retrospective analysis of data reported earlier in an investigation studying the 
impact of ganglionic blockade on synchronous AP de-recruitment (24). Here, we focus 
on the patterns of asynchronous APs. Trimethaphan infusion rate was adjusted over time, 
and variably across participants until ganglionic blockade was achieved. In this study, 
ganglionic blockade was defined as participants exhibiting no visible integrated MSNA 
bursts and < 5 bpm change in HR from BSL during phase II of Valsalva’s Manoeuvre. 
Data analysis was performed on 181 ± 1 s at BSL, the last 86 ± 16 s with visible 
integrated bursts during the trimethaphan infusion, and 120 ± 0 s of the trimethaphan 
infusion where integrated bursts were not visible. Additional information regarding this 
experimental design is available elsewhere (24). 
3.2.5 Experimental Measures and Analysis 
Continuous postganglionic muscle sympathetic c-fibre discharge was measured by 
microneurography at the peroneal nerve using the same equipment and settings in each 
experiment (16). MSNA recordings were confirmed by the absence of skin paresthesia 
and an increase in bursting discharge upon voluntary APN, but not during arousal to a 
loud noise (40). Postganglionic sympathetic activity was recorded with a nerve traffic 
analyzer (662C-3; Bioengineering University of Iowa, Iowa City, IA). The neural signal 
was pre-amplified with a gain of 1,000 (using preamplifier and isolation amplifier; gains 
of 100 and 10, respectively), then further amplified with a gain of 75 (using a variable 
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gain amplifier). Neural activity was then band-pass filtered (bandwidth of 700–2,000 Hz) 
before being rectified and integrated (using a leaky integrator; 0.1-s time constant). The 
filtered and integrated microneurographic signals were sampled at 10,000 Hz while all 
other signals were sampled at 1,000 Hz. Data were collected using LabChart 8 and 
PowerLab systems (ADInstruments; Castle Hill, New South Wales, Australia) then saved 
for offline analysis.  
Prior to analysis, integrated and filtered MSNA signals were time adjusted for the 
conduction delay, which was derived from the burst latency (see below) of several 
varying-sized integrated bursts. Integrated MSNA bursts were included in the analysis if 
they aligned with an R-wave and exhibited a 2:1 ratio relative to the previous period of 
between-burst signal. Integrated MSNA burst occurrence was quantified as burst 
frequency (bursts/min) and burst incidence (bursts/100beats). Burst amplitude (AU) was 
measured in volts and normalized to the largest burst at BSL. The product of burst 
frequency and normalized amplitude yielded a metric of total MSNA (AU/min). Burst 
latency (s) was the time difference between the ECG R-wave and the peak of the 
corresponding integrated burst.  
In both experiments, muscle sympathetic APs in the filtered neurogram were detected 
using a continuous wavelet transform, described in detail previously (32). Throughout all 
study conditions any detected APs were extracted, regardless of their temporal coherence 
with an integrated MSNA burst. For each condition all extracted APs were ordered based 
on peak-to-peak amplitude then assigned to a bin (i.e., cluster) following Scott’s rule 
which balances bin width, data bias, and variance to minimize integrated mean square 
error (35). Consequently, the number of bins varies across participants and conditions. To 
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resolve this, AP bin properties were normalized for each participant to ensure that 
minimal bin width (value selected from the condition with the smallest bins), total 
number of bins (value selected from the condition with the greatest number of bins), and 
maximum bin centre (value selected from the condition with the greatest maximal bin 
centre) were identical across conditions. This allowed us to detect whether APs were 
recruited or de-recruited from BSL during physiological stress or ganglionic blockade, 
respectively, and to compare the behaviour of each cluster between conditions.  
Following binning, APs were determined to be firing synchronously or asynchronously 
based on the following criteria (Fig. 3.1): An AP was considered to fire synchronously 1) 
if its occurrence corresponded with a burst (as defined above) in the integrated MSNA 
signal (i.e., within ± 0.4 s of the burst peak), or 2) despite no visible integrated burst, if it 
was one of  ³ 2 visible APs in the filtered microneurographic signal firing within ± 0.4 s 
of an ECG R-wave (after adjusting for the conduction delay). All other APs were 
considered to fire asynchronously. For HR > 75 bpm the window for synchronous AP 
detection was reduced to one-half the R-R interval. This approach will necessarily 
underestimate the occurrence of those asynchronous APs that also occur during a burst 
period (either spontaneously or through some synchronization process).  
The signal-to-noise ratio (SNR) was determined as the amplitude of the negative peak of 
the mean AP over the standard deviation of the background noise around each AP. In 
Experiment One the SNR values at BSL (4.0 ± 0.4), -10 mmHg LBNP (4.1 ± 0.4), -40 
mmHg LBNP (4.1 ± 0.4), and end-expiratory apnea (4.2 ± 0.5) enabled a correct 
detection rate of >95% and a false positive rate of <3% (32). As reported previously (24), 
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in Experiment Two the SNR at BSL and the trimethaphan infusion were 4.2 ± 0.7 and 4.2 
± 0.5, respectively.  
Asynchronous APs were quantified by AP frequency (AP/min) and total AP clusters. The 
time between bursts of synchronized APs was used to calculate the asynchronous AP 
frequency. Synchronous APs were quantified by AP frequency (AP/min), incidence 
(AP/100beats), the number of APs per integrated burst, the number of unique AP clusters 
per burst and total AP clusters. For synchronous APs, latency was determined as the time 
difference from the R-wave of the preceding cardiac cycle to the negative peak of the AP 
(33). Synchronous AP cluster latency was determined as the mean latency of all APs 
within a cluster. The relationship between synchronous AP cluster latency and cluster 
size was fitted with an exponential decay function. The probability of asynchronous AP 
activity (%) was quantified for each AP cluster by taking the number of asynchronous 
APs that fired in a given condition divided by the total number of active APs 
(asynchronous and synchronous) within each cluster, multiplied by 100%. Distributions 
of asynchronous firing across clusters were constructed. The total probability of 
asynchronous AP activity (%) was calculated as the number of asynchronously firing APs 
regardless of cluster divided by the total number of active APs (asynchronous and 
synchronous), multiplied by 100%.  
3.2.6 Statistical Analysis 
In Experiment One, a repeated-measures analysis of variance (RM ANOVA) assessed the 
effect of study conditions (i.e., BSL, -10 mmHg LBNP, -40 mmHg LBNP, and APN) on 
AP patterns. For Experiment Two, RM ANOVAs evaluated differences in asynchronous 
AP discharge between BSL, the last minute of the trimethaphan infusion, and the period 
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of the trimethaphan infusion without visible bursts. For both experiments, post-hoc t-tests 
with a Holm-Bonferroni (20) correction were employed for significant RM ANOVAs to 
expose which conditions were different from BSL. The relationship between the 
probability of asynchronous firing or asynchronous AP frequency and normalized cluster 
size was fitted with a logarithmic function. Bland-Altman agreement analysis assessed 
the repeatability of asynchronous discharge across different segments at BSL. Statistical 
analyses were performed with SPSS Statistics (v 25, IBM Corp., Armonk, NY, USA). 
Tests were two tailed with α = 0.05. Data are reported as mean ± standard deviation 
unless stated otherwise. 
3.3 Results 
Experiment One: Quantifying AP synchronicity during baseline, baroreflex, and 
apneic stress 
Analyses were performed on a total of 607 ± 294 APs (183 ± 99 asynchronous APs), 490 
± 260 APs (114 ± 59 asynchronous APs), 753 ± 369 APs (107 ± 67 asynchronous APs), 
and 197 ± 79 APs (24 ± 14 asynchronous APs) at BSL, -10 mmHg LBNP, -40 mmHg 
LBNP, and APN, respectively in Experiment One. 
Compared with BSL, total integrated MSNA increased due to greater burst occurrence in 
-10 mmHg LBNP, and due to greater burst occurrence and amplitude during -40 mmHg 
LBNP and APN (Table 3.1). Compared to BSL, changes in the integrated measures of 
MSNA with -10 mmHg LBNP, -40 mmHg LBNP, and APN were attributed to the 
increased occurrence of synchronously firing APs and the number of synchronous APs 
per burst. In this study, the total number of synchronously firing AP clusters was 
unchanged, but the number of unique AP clusters firing synchronously in bursts was 
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increased in all experimental conditions, relative to BSL (Table 3.1). While there was a 
main effect of experimental condition (both RM ANOVA P < 0.05) for both integrated 
burst and synchronous AP latencies, post-hoc tests revealed no differences on going from 
BSL to -10 mmHg LBNP, -40 mmHg LBNP, and APN (Table 3.1). Hemodynamic 
variables across conditions are presented in Table 3.1.  
At BSL (R2 = 0.42, P < 0.05), -10 mmHg LBNP (R2 = 0.54, P < 0.05), -40 mmHg LBNP 
(R2 = 0.74, P < 0.05), and APN (R2 = 0.47, P < 0.05) synchronous AP cluster latency was 
related to cluster size, as modelled by an exponential decay function. Consistent with 
previous work (37), these data support the concept that the synchronous AP clusters 
detected here scaled to the diameter of the sympathetic c-fibres within the 
microneurographic recording field. 
The representative data from one participant presented in Figure 3.2 demonstrate the 
between-burst asynchronous sympathetic AP discharge that exhibited weak cardiac-
rhythmicity across all experimental conditions. During BSL, 33 ± 12 % of total APs fired 
asynchronously. Compared to BSL, the probability of asynchronous AP activity 
decreased with -10 mmHg LBNP (26 ± 10 %), -40 mmHg LBNP (15 ± 7 %), and APN 
(14 ± 7 %) (Condition Main Effect: P < 0.05; all PPost-hoc < 0.05) (Fig. 3.3). However, 
these changes were attributed to greater synchronous discharge (i.e., increased burst 
frequency) as asynchronous AP frequency (i.e., APs observed in the absence of bursts) 
was not different from BSL (67 ± 37 AP/min) to -10 mmHg LBNP (69 ± 33 AP/min), -40 
mmHg LBNP (83 ± 68 AP/min), or APN (62 ± 39 AP/min) (Condition Main Effect: P > 
0.05) (Fig. 3.3). Compared to baseline (11 ± 5 clusters), the total number of asynchronous 
clusters was similar at -10 mmHg LBNP (12 ± 5 clusters, P Post-hoc > 0.05) and -40 mmHg 
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LBNP (12 ± 5 clusters, P Post-hoc > 0.05), but reduced with APN (6 ± 2 clusters; P Post-hoc < 
0.05) (Condition Main Effect: P < 0.05). Males and females exhibited similar 
asynchronous behaviour across experimental conditions. As depicted in Figure 3.4, when 
APs were arranged by peak-to-peak amplitude and clusters were normalized across 
conditions, asynchronous APs exhibited similar morphologies to the synchronously firing 
APs within the same cluster, across all conditions.  
When asynchronous APs were sorted by peak-to-peak amplitude and assigned to 10 
normalized clusters, a pattern emerged whereby the asynchronous probability decreased 
as a logarithmic function of AP cluster size (i.e., smaller APs were more likely to fire 
asynchronously) across all conditions (BSL: R2 = 0.90, P < 0.05; -10 mmHg LBNP: R2 = 
0.82, P < 0.05; -40 mmHg LBNP: R2 = 0.74, P < 0.05; APN: R2 = 0.84, P < 0.05) (Fig. 
3.5). A similar logarithmic relationship was observed for asynchronous AP frequency. 
Examining the size-distribution of normalized AP clusters demonstrated that AP 
frequency was consistent for all clusters across the experimental conditions (Fig. 3.5). 
Experiment Two: Exploring ganglionic mechanisms contributing to AP 
synchronicity 
This results section describes the role of the sympathetic paravertebral ganglia in AP 
synchronicity. In our previous study (24) examining synchronous AP discharge during 
ganglionic blockade, we identified that trimethaphan infusion produced an ordered de-
recruitment of synchronous APs beginning with the larger APs active at BSL, followed 
by reductions in the occurrence of smaller synchronous APs. After several minutes of the 
trimethaphan infusion, integrated bursts of MSNA were no longer visible, yet we 
recorded a population of smaller, trimethaphan-resistant APs. As reported previously 
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(24), HR increased and mean arterial pressure decreased from BSL (57 ± 11 bpm, 97 ± 7 
mmHg) to the last minute of trimethaphan with visible bursts (66 ± 12 bpm, 90 ± 7 
mmHg) and the period of the trimethaphan infusion where bursts were abolished but 
trimethaphan-resistant APs persisted to fire (80 ± 6 bpm, 87 ± 12 mmHg) (Condition 
Effect for both HR and BP: P < 0.05, all PPost-hoc < 0.05).   
Analyses for Experiment Two were performed on a total of 620 ± 311 APs (148 ± 43 
asynchronous APs), 88 ± 52 APs (70 ± 50 asynchronous APs), and 76 ± 63 APs (all APs 
were deemed asynchronous) at BSL, the last minute of the trimethaphan condition with 
visible bursts, and the period of the trimethaphan condition where bursts had been 
abolished, respectively. 
As highlighted by one participant’s data in Figure 3.6, the present study tracked and 
quantified both synchronous and asynchronous AP discharge from BSL to the last minute 
of the trimethaphan condition with visible integrated bursts, and the period of the 
trimethaphan infusion where visible bursts had been blocked but a population of smaller 
APs persisted to fire asynchronously. In the current analysis, trimethaphan infusion was 
associated with de-recruitment of larger asynchronous APs. Compared to BSL (11 ± 4 
AP clusters), the total number of asynchronous clusters was reduced in the final minute 
of the trimethaphan infusion with visible bursts (7 ± 2 AP clusters), and during the period 
of the trimethaphan infusion where bursts were no longer visible (6 ± 2 AP clusters) 
(Condition Main Effect P < 0.05; both PPost-hoc < 0.05). Relative to BSL (29 ± 16 %), the 
total probability of asynchronous AP firing increased in the final minute of the 
trimethaphan infusion with visible bursts (76 ± 13 %; PPost-hoc < 0.05) and further 
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increased to 100 ± 0 % (PPost-hoc < 0.05) during the period of the trimethaphan infusion 
where smaller APs persisted to fire without visible bursting (Condition Main Effect P < 
0.05). However, these changes were attributed to reductions in synchronous AP firing in 
bursts with trimethaphan as asynchronous AP frequency did not change from BSL (53 ± 
15 AP/min) to the last minute of the trimethaphan infusion with visible bursts (47 ± 23 
AP/min), or the period of the trimethaphan infusion without visible bursts [38 ± 31 
AP/min; (24)] (Condition Main Effect: P > 0.05).  
When asynchronous APs were sorted by peak-to-peak amplitude and assigned to 10 
normalized clusters, asynchronous AP probability decreased as a logarithmic function of 
cluster size at BSL (R2 = 0.93, P < 0.05) and this relationship was maintained but shifted 
upwards for the smaller asynchronous APs continuing to fire during the last minute of the 
trimethaphan condition with visible bursts (R2 = 0.70, P < 0.05) (Fig. 3.7). When visible 
bursts had been abolished by trimethaphan, the smallest APs that expressed the greatest 
asynchronous probability at BSL continued to fire asynchronously without producing 
bursts (Fig. 3.7). Trimethaphan de-recruited the largest asynchronous APs but did not 
alter the firing rate across the size-distribution of the smaller asynchronous APs (Fig. 
3.7). 
Repeatability Analysis  
Bland-Altman plots (not shown) constructed with data from two BSL periods (BSL 
Period One: 199 ± 20 s, BSL Period Two: 176 ± 54 s) from a sub-sample of 8 individuals 
(n = 4 participants from Experiment Two; n = 5 females) revealed strong agreement for 
the probability of asynchronous APs (BSL Period One: 30 ± 15 %, BSL Period Two: 30 
± 13 %; mean difference: 1 ± 5 %, mean absolute difference: 4 ± 3 %) and asynchronous 
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AP frequency (BSL Period One: 45 ± 15 AP/min, BSL Period Two: 43 ± 19 AP/min; 
mean difference: -1 ± 8 AP/min, mean absolute difference: 6 ± 8 AP/min). For both 
variables, all data points fell within two standard deviations of the mean difference. 
Neither variable exhibited fixed bias (both P > 0.67). When differences between baseline 
periods were regressed against the mean of the baseline periods, asynchronous AP 
probability and asynchronous AP frequency did not express proportional bias (both P > 
0.14).   
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Table 3.1 Hemodynamic, integrated muscle sympathetic nerve activity, and synchronous 
































Figure 3.1 Criteria employed to discriminate between synchronous and asynchronous 
action potentials (AP) during analysis. Electrocardiogram (ECG), integrated muscle 
sympathetic nerve activity (MSNA), filtered MSNA, and detected APs from one 
individual. Synchronous AP criterion A: APs were considered to fire synchronously if 
their occurrence corresponded with ± 0.4 s from the peak of an integrated MSNA burst. 
Synchronous AP criterion B: When no integrated burst was apparent, APs were 
considered to fire synchronously if at least 2 APs were visible in the filtered neurogram 
and occurred within ± 0.4 s of an ECG R-wave. For HRs ≥ 75 bpm the window for 
synchronous APs was reduced to one-half of the R-R interval for that beat. The 
neurogram was corrected for the conduction delay. Arrows indicate three APs visible 
within the filtered neurogram. APs that did not satisfy these two criteria were deemed 




















Figure 3.2 Representative data from one participant depicting the electrocardiogram 
(ECG), blood pressure (BP), integrated muscle sympathetic nerve activity (MSNA), 
filtered MSNA, and detected action potentials (AP) at baseline (BSL) (A), -10 mmHg 
lower body negative pressure (LBNP) (B), -40 mmHg LBNP (C), and the onset of end-
expiratory apnea (APN). Data selections illustrate synchronous AP discharge [indicated 
by asterisks (*)] often forming bursts and asynchronous APs firing between bursts for 
each study condition. Notice in the APN data selection, as indicated by the arrow and 
dashed line, that some asynchronous APs fired without cardiac rhythmicity between two 


















Figure 3.3 Probability (A) and frequency (B) of asynchronous action potential (AP) 
discharge at BSL (BSL), -10 mmHg lower body negative pressure (LBNP), -40 mmHg 
LBNP, and end-expiratory apnea (APN). Mean ± SD for each condition are represented 
by filled circles and error bars. Individual data are represented by thin grey lines. P 
values for main effect of condition obtained with RM ANOVA are reported. *, indicate 














Figure 3.4 Representative morphologies of synchronously (left black tracing within each 
panel) and asynchronously (right grey tracing within each panel) discharging action 
potential (AP) clusters, detected in one participant during BSL (BSL), -10 mmHg lower 
body negative pressure (LBNP), -40 mmHg LBNP, and end-expiratory apnea (APN). AP 
clusters were binned based on peak-to-peak amplitude. n = 1986 synchronous and n = 
454 asynchronous APs fired across all conditions. Thick and thin lines represent means 
and standard deviations of cluster amplitude, respectively. Clusters without a mean AP 











Figure 3.5 Asynchronous AP probability (A) and asynchronous AP frequency (B) versus 
normalized AP cluster (normalized to 10 clusters; e.g., cluster 1 represents 0-10% of 
largest cluster detected across all conditions) at baseline (BSL), -10 mmHg lower body 
negative pressure (LBNP), -40 mmHg LBNP, and end-expiratory apnea (APN). A and B: 
Mean ± SE for each cluster are represented by filled circles and error bars. A: data from 














Figure 3.6 Representative data from one participant depicting the electrocardiogram 
(ECG), blood pressure (BP), integrated muscle sympathetic nerve activity (MSNA), 
filtered MSNA, and detected action potentials (AP) at baseline (BSL), the last minute of 
the trimethaphan infusion with visible bursts (TM Last Min), and the period of the 
trimethaphan infusion with no visible bursts (TM No Burst). Data selections illustrate 
synchronous AP discharge [indicated by asterisks (*)] often forming bursts and 
asynchronous APs firing between bursts for BSL and TM Last Min and without bursts in 








Figure 3.7 Asynchronous AP probability (A) and asynchronous AP frequency (B) versus 
normalized AP cluster (normalized to 10 clusters; e.g., cluster 1 represents 0-10% of 
largest cluster detected across all conditions) at BSL (BSL), the last minute of 
trimethaphan with visible bursts (TM Last Min), and the period of the trimethaphan 
infusion with no visible bursts (TM No Burst). A and B: Mean ± SE for each cluster are 
represented by filled circles and error bars. A: data from BSL and TM Last Min were 
fitted with logarithmic functions. No error bars are visible for TM No Burst as all clusters 
expressed 100% asynchronous probability (n =7). B: No error bars are visible for the 
BSL firing frequency of larger clusters due to small variability (n = 7). Notice that at BSL 
all sized APs fired asynchronously but smaller APs expressed the greatest probability of 
asynchronous activity. Trimethaphan de-recruited larger asynchronous APs but had no 





The present study provides novel insight to the fundamental behaviour of sympathetic 
discharge directed towards the circulation in humans. Specifically, we report 
asynchronous AP discharge during periods conventionally thought to represent ‘neural 
silence’ between bursts of synchronously firing sympathetic APs. At BSL, asynchronous 
AP discharge accounted for approximately 30% of total sympathetic AP activity in each 
of two separate experiments where data were obtained from two different laboratories. 
Asynchronous AP frequency (measured between bursts) remained constant across 
varying degrees of stress. However, the probability of asynchronous APs decreased with 
physiological stress due to increased synchronous AP discharge and burst frequency. 
Importantly, asynchronous discharge was not uniform across differently-sized APs, as the 
probability of asynchronous firing was reduced as cluster size increased. Through 
trimethaphan infusion in a group of females, we observed that the trimethaphan-
resistance property of smaller APs, which we hypothesized earlier (24) to represent non-
nicotinic ganglionic mechanisms, contributes to asynchronous discharge of smaller APs 
in humans.  
Previous investigations employing single- (26) and multi-fibre microneurography (37) 
have exposed the fundamental AP patterns contributing to the variability in integrated 
burst size and frequency in humans. By studying all active APs in the current analysis, 
rather than just those that are found within identified bursts, we observed asynchronous, 
between-burst AP activity in healthy individuals and replicated this finding during BSL 
conditions in a separate group tested in a different laboratory. To our knowledge, this 
study describes the first quantification of synchronicity and report of asynchronous 
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discharge within the human sympathetic nervous system. Nonetheless, several studies in 
felines have documented asynchronous behaviour in the sympathetic neurogram (10, 11, 
19, 22) (discussed in detail below). Asynchronously discharging APs have also appeared 
in figures from microneurographic recordings made in humans by multiple laboratories 
(25, 30, 34) but have remained unquantified. Of note, in the present study, asynchronous 
behaviour was heterogenous, with proportions decreasing logarithmically with increasing 
cluster size, in both experiments. This observation aligns with previous evidence 
indicating non-uniform discharge, recruitment, and regulation across the size distribution 
of recorded APs (33, 34, 38). Asynchronous AP size likely scaled to sympathetic axon 
diameter as these APs were similar in morphology to the synchronous APs which 
expressed an exponential decay relationship between cluster latency and size.  In fact, 
this observation suggests that asynchronous APs were also present within the burst 
periods. Whether this synchronization process was due to a time-varying synchronization 
mechanism, or simply, to random patterns of AP firing, sometimes falling at the time of a 
synchronized burst, remains unknown. Unfortunately, our approach to AP detection does 
not allow determination of whether the AP clusters that are observed between bursts (i.e., 
asynchronous) and within a burst (i.e., synchronized) arise from the same axon.  
The physiological relevance of asynchronous APs remains a compelling question. During 
stress (e.g., orthostatic, apneic, chemical, etc.) the sympathetic nervous system increases 
the firing rate of previously active synchronous APs and recruits in a synchronized 
fashion a subpopulation of previously silent, larger APs increasing integrated burst size 
along with burst occurrence (4–7, 27). In contrast, under the conditions of physiological 
stress imposed here, the asynchronous APs do not appear to follow the same rules. It is 
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clear that bursty patterns of postganglionic sympathetic APs provide the most robust 
vasoconstrictor response (2, 3). Therefore, one explanation could be that asynchronous 
AP discharge represents an additional sympathetic communication strategy for 
maintenance of baseline vasomotor control and have less impact on stress-related 
vasoactive outcomes. During times of stress, this subpopulation of asynchronously firing 
APs may contribute to vasomotor regulation by firing within bursts through coincidental 
capture or some active AP synchronization mechanism. For example, the observation of 
unchanged asynchronous firing rate but greater burst frequency on going from BSL to 
baroreflex and apneic stress suggests a greater probability of coincidental incorporation 
of asynchronous APs in bursts. The finding that fewer asynchronous AP clusters fired 
during APN compared to BSL may point towards a stress-specific AP synchronization 
process. Both hypotheses represent additional mechanisms for increasing within-burst AP 
content during stress, beyond the recruitment of larger axons or increasing the firing rate 
of previously active synchronous axons. 
Complex neural mechanisms likely govern synchronicity among human muscle 
sympathetic c-fibres. Here, in a group of women, we identified that trimethaphan de-
recruited the largest asynchronously firing APs. However, smaller APs, which expressed 
the greatest asynchronous discharge at BSL (and across all conditions in Experiment 
One) persisted to fire throughout the trimethaphan infusion, demonstrating resistance to 
trimethaphan, as synchronous discharge dissipated. We interpret these data to suggest 
that nicotinic ganglionic mechanisms participate in the regulation of synchronous and 
asynchronous neuronal discharge and burst production, and that non-nicotinic 
mechanisms contribute to the regulation of a subpopulation of small diameter 
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asynchronously discharging postganglionic axons. The notion that the ganglia affect the  
synchronicity among sympathetic neurons has been tested in cats. These earlier studies 
noted that stimulation of preganglionic fibres or hypothalamic nuclei elicited a bimodal 
postganglionic response characterized by a rapid-onset synchronous discharge, followed 
by a delayed, longer-lasting asynchronous discharge (10, 11, 19). Furthermore, the rapid-
onset burst of activity to preganglionic stimulation in these experimental models was 
consistently abolished by nicotinic receptor antagonists, whereas muscarinic antagonists 
eliminated asynchronous firing (10, 11, 19, 22). In canines, a nicotinic-muscarinic 
interaction mediated the firing of a discrete subpopulation of postganglionic 
vasoconstrictor fibres that were activated by chemical stress and resistant to nicotinic 
blockade (18). Peptidergic and purinergic ganglionic co-transmission may also contribute 
to asynchronous AP firing (14, 21).  
Additional factors beyond ganglionic mechanisms may contribute to asynchronous AP 
discharge. We base this conjecture on the finding that asynchronous firing was observed 
across all AP clusters, not just the smaller APs expressing trimethaphan-resistance. One 
possibility is the baroreflex effect that exerts considerable influence over the cardiac-
gated bursty pattern of MSNA (12, 29). Our previous study examining only 
synchronously firing APs revealed that small-to-moderate sized APs received 
considerable baroreflex influence whereas the larger APs did not (34). This may be 
attributed to sympathetic neurons projecting directly from supra-medullary sites (e.g., 
paraventricular hypothalamus or pons) to spinal neurons, as documented in rats (39). 
Specifically, the current analysis revealed that asynchronous APs did not always exhibit 
cardiac rhythmicity and asynchronous AP frequency remained constant in both 
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experiments across a range of HRs and BPs, suggesting that features of baroreflex or 
cardiac afferent inputs do not modulate completely this population of sympathetic 
neurons. Also, the rhythmicity – due to intrinsic pacemaker behaviour and/or neural 
inputs – of extra-baroreflex supra-medullary and spinal nuclei likely exert additional 
control over AP synchronization, but how these sites interact with the baroreflex to shape 
postganglionic discharge requires investigation (1, 8, 15, 28). Combined, our two 
experiments suggest that compared to synchronously discharging axons, the 
postganglionic c-fibres generating asynchronous APs are governed differently at the 
central and/or peripheral level of the sympathetic organization. 
We are confident that all APs reflected sympathetic postganglionic axonal firing for the 
following reasons. First, the continuous wavelet technique used here extracts APs 
matching real human muscle sympathetic APs (32). Inspection of all extracted AP 
clusters revealed the prototypical extracellular sympathetic c-fibre morphology as 
obtained by the hardware and signal processing employed by our laboratory (38) and 
others (13). Second, the microneurographic recordings were made from muscle 
sympathetic bundles only, as in each participant the neural signal expressed spontaneous 
pulse-rhythmic bursting that increased during apnea but not with arousal to a loud noise 
or when stroking the skin (16). Third, based on the high-quality nerve recordings our AP 
detection software operates with a false detection rate of less than 3% (32). While the 
possibility remains, the abovementioned lines of evidence minimize the likelihood that 
our analysis included sympathetic APs other than those originating from muscle 




 This study advances our knowledge of the sympathetic neural communication strategies 
contributing to circulatory regulation. Particularly, we identified that asynchronous AP 
discharge, rather than complete ‘neural silence’, exists between bursts of synchronously 
firing sympathetic APs, and the degree of asynchronous discharge scales inversely to AP 
size, such that smaller APs express the greatest probability of asynchronous firing. Thus, 
approaches to MSNA quantification that rely on signal integration (16), or focusing on 
within-burst AP discharge using single- (27) or multi-unit (38) techniques, appear to 
underestimate and conceal a fundamental element of muscle sympathetic AP discharge. 
During a physiological challenge, the inclusion of previously asynchronous APs into 
bursts may represent an additional strategy to increase burst size. Based on patterns of AP 
behaviour during the trimethaphan infusion, we propose that non-nicotinic receptors at 
the ganglia underlie asynchronous behaviour, at least for the smaller AP clusters. 
However, central sympathetic mechanisms such as reduced baroreflex control of discrete 
AP subpopulations may also generate asynchronous firing. The current findings represent 
an additional layer of intricacy contained within the neural language of the sympathetic 
nervous system as well as a component of the neural organization subserving this 
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4 Baroreflex control of sympathetic action potential 
subpopulations during orthostatic stress 
 
4.1 Introduction 
Pulse-rhythmic feedback from arterial baroreceptors synchronizes action potential (AP) 
discharge to produce the characteristic bursty pattern of muscle sympathetic nerve 
activity (MSNA) (5, 7, 35). While the baroreflex imposes strong regulation over the 
frequency of these bursts, burst amplitude –– a function of the size and number of 
synchronously firing APs –– exhibits only weak baroreflex control (14, 24, 37). This 
stems from the baroreflex exerting differential control over the varying-sized sympathetic 
APs (representing different sized axons) synchronized to fire in bursts (31). Specifically, 
under baseline conditions, the arterial baroreflex strongly governs medium-sized APs, 
which fire in most bursts, but minimally governs larger AP clusters, which fire with low 
probability and contribute proportionately more to larger bursts (31, 35). Also, small APs 
may not be governed strongly by the arterial baroreflex. In fact, we reported that 30% of 
total APs fired asynchronously outside baroreflex-gated bursts at baseline, with smaller 
APs expressing the greatest proportion of asynchronous discharge (17). 
Arterial baroreflex-mediated sympathetic arousal represents a critical mechanism for 
blood pressure regulation during orthostatic stress (8, 33). Unlike other forms of stress 
(e.g., chemical, metabolic, or apneic) (15, 20, 34), baroreflex unloading represents a weak 
reflex when it comes to recruiting larger, latent AP clusters (i.e., high-threshold axons) 
until severe levels, such as -80 mmHg lower body negative pressure (LBNP), with some 
110 
 
inter-individual variability (2, 29). Thus, the baroreflex relies primarily on increasing the 
firing probability of previously-active APs (i.e., low-threshold axons) to elicit 
sympathoexcitation during orthostatic stress (29). Yet, the precise mechanisms 
subserving the enhanced firing rate remain unclear. Based on the observation that 
medium AP clusters express strong baroreflex regulation under baseline conditions (31) 
we reasoned that the upward shift in baroreflex control over integrated bursts of MSNA 
during orthostatic stress (11, 12, 29) might be related to specific control over these 
medium AP clusters along with relocation of the operating points to positions of greater 
gain to facilitate enhanced discharge. However, observations made during the 
hypotensive phase of a modified Oxford test of reduced firing probability of the cluster of 
the smallest APs (18) suggest that this subpopulation may express reductions in 
baroreflex control during orthostatic stress.  
Therefore, this study aimed to examine the heterogeneity of baroreflex control over AP 
discharge by measuring the baroreflex gain of all AP clusters. This research tested the 
hypothesis that during orthostatic stress the baroreflex confers its greatest effect on the 
gain of medium AP clusters that fire normally with high probability. If so, then the 
change in position and slope of each AP cluster’s baroreflex curve should vary across the 
distribution of recorded APs. 
4.2 Methods 
4.2.1 Ethical Approval 
This study received approval from the Health Sciences Research Ethics Board at the 
University of Western Ontario (No. 108026). This study conforms to the Declaration of 
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Helsinki, except for registration in a database. Each participant provided informed written 
consent to the study following verbal and written explanations of study procedures 
4.2.2 Sample 
Six healthy young individuals (3 females) participated in this study (26 ± 1 years, 170 ± 2 
cm, 70 ± 6 kg). Participants were normotensive and were free of cardiovascular or 
neurological disease. This study did not control for oral contraceptive use or stage of the 
menstrual cycle in females (39).  
4.2.3 Experimental Procedures and Protocol.  
Participants arrived at the Laboratory for Brain and Heart Health at the University of 
Western Ontario after a 4-hr fast and avoiding alcohol and caffeine consumption, and 
vigorous physical exercise for 12 hours. Participants were instructed to empty their 
bladder after which they assumed the supine position with their lower body sealed below 
the iliac crest in a LBNP chamber for the duration of the study. Participants were 
familiarized with a bout of LBNP prior to commencing the experimental protocol. 
Data collection began following at least 30 minutes in the supine position. The 
experimental protocol consisted of: 1) at least 5 minutes under baseline (BSL) conditions, 
2) 3 – 5 mins exposure to -40 mmHg LBNP, and 3) 3 – 5 mins exposure to -80 mmHg. 
The order of tests was not randomized or varied due to the greater risk of signal loss at 
the higher level of lower body suction. The maximal LBNP level that provided high 
quality microneurographic data was analyzed for each participant. LBNP -40 mmHg was 
used for two participants (1 female) and LBNP -80 was used for four participants. Similar 
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changes in baroreflex gain were observed on going from BSL to either -40 mmHg or -80 
mmHg LBNP so these levels were collapsed into a single LBNP condition. 
4.2.4 Experimental Measures and Analysis.  
A 3-lead ECG measured heart rate (BioAmp FE132, ADInstruments; Bella Vista, New 
South Wales, Australia). Beat-by-beat blood pressure was measured by finger 
photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The 
Netherlands) with the Modelflow algorithm providing stroke volume and cardiac output 
(40). Reconstructed brachial blood pressures were calculated and used for analysis. Total 
peripheral resistance was calculated as the quotient of mean arterial pressure and cardiac 
output. A calibrated pressure sensor measured chamber pressure (MLT0670, 
ADInstruments; Castle Hill, New South Wales, Australia). 
Continuous muscle sympathetic postganglionic c-fibre discharge was measured from the 
common peroneal nerve as described originally by Hagbarth and Vallbo (9), and recently 
by our laboratory (16, 17). Postganglionic sympathetic activity was recorded with a nerve 
traffic analyzer (662C-3; Bioengineering University of Iowa, Iowa City, IA). The neural 
signal was pre-amplified with a gain of 1,000 (using preamplifier and isolation amplifier; 
gains of 100 and 10, respectively), then further amplified with a gain of 75 (using a 
variable gain amplifier). Neural activity was then band-pass filtered (bandwidth of 700–
2,000 Hz) before being rectified and integrated (using a leaky integrator; 0.1-s time 
constant). Muscle sympathetic nerve activity (MSNA) was confirmed by the absence of 
skin paresthesia and the observation of an increase in bursting during a volitional apnea, 
but not arousal to a loud noise. Filtered and integrated MSNA signals were sampled at 
10,000 Hz, while all other signals were sampled at 1,000 Hz. LabChart 8 and PowerLab 
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systems (ADInstruments; Bella Vista, New South Wales, Australia) enabled data 
collection, storage, and analysis.  
Integrated MSNA bursts were analyzed if they aligned with an R-wave and exhibited a 
2:1 ratio relative to the previous period of between-burst signal. Burst frequency 
(bursts/min), burst incidence (bursts/100beats), and burst amplitude (AU) normalized to 
the largest burst at BSL, provided metrics of the integrated MSNA.  
As described previously (28), sympathetic APs were extracted from the filtered 
neurogram using a continuous wavelet transform. Based on our previous finding that a 
considerable amount of AP discharge occurs asynchronously between bursts (17), any AP 
that was detected during BSL and LBNP was extracted regardless of whether or not it 
occurred within an identified burst of MSNA. APs were ordered based on peak-to-peak 
amplitude and sorted into bins (i.e., clusters) using Scott’s rule. Within each participant, 
AP bin properties were normalized to ensure that bin width, bin number, and maximum 
bin centre were identical between BSL and LBNP. This strategy enables quantification of 
the number of AP clusters that were recruited from BSL to LBNP and the change in 
firing probability for each cluster. Moreover, to enable between-participant comparisons 
of AP cluster activity, data were normalized to the largest AP cluster (which fired during 
LBNP in all participants) and assigned to 15 clusters. The signal-to-noise ratio (SNR) 
was determined as the amplitude of the negative peak of the mean AP over the standard 
deviation of the background noise around each AP at BSL (3.9 ± 0.1) and LBNP (4.1 ± 
0.1). These values of SNR will ensure a correct detection rate of ~95% and a false 
positive rate of <3% (28). 
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During each condition, AP behaviour was quantified by AP frequency (AP/min), 
incidence (AP/100beats), and the total number of AP clusters (total bins). In heartbeats 
with AP discharge, AP behaviour was also quantified by the number of APs per heartbeat 
(spikes/beat) and the number of unique clusters per heartbeat (bins/beat). The firing 
probability (%) of each cluster was calculated as the quotient of the total number of times 
each cluster fired and the total number of heartbeats, multiplied by 100%.  
4.2.5 Integrated baroreflex threshold and sensitivity  
For both experimental conditions, baroreflex threshold and sensitivity analyses were 
performed for integrated bursts and AP clusters following the nomenclature employed 
previously (10, 14, 31). Baroreflex threshold analysis for integrated bursts involved 
grouping the diastolic blood pressures (DBP) of individual heartbeats into 2-mmHg bins 
and calculating the burst probability (%) for each DBP bin: that is, the percentage (%) of 
heartbeats per DBP bin that were associated with an integrated burst. Integrated 
baroreflex threshold gain for burst occurrence was measured as the slope of the linear 
relationship between burst probability versus the mean DBP for each bin. Baroreflex 
sensitivity gain for integrated burst size was measured as the slope of the relationship 
between individual normalized burst amplitude versus the corresponding DBP. For all 
regressions, Pearson’s correlation coefficients were recorded. For both experimental 
conditions, the operating point was determined for integrated baroreflex threshold and 
sensitivity diagrams by plotting the point of intersection of mean burst probability or 
amplitude, respectively, and mean DBP.  
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4.2.6 Action potential baroreflex threshold and sensitivity  
Baroreflex threshold analysis for AP occurrence was performed for each AP cluster based 
on a previously described method (31). Consistent with above, DBPs were grouped into 
2-mmHg bins and AP probability (%) for each bin was calculated. For each cluster, 
baroreflex threshold gain was measured as the slope of the linear relationship between 
AP probability versus the mean DBP for each bin. AP baroreflex sensitivity gain was 
calculated as the slope of the linear relationship between the number of unique AP 
clusters that fired in each heartbeat versus the DBP for that beat. Pearson’s correlation 
coefficients were recorded for each regression. For both experimental conditions, the 
operating point was determined for AP cluster baroreflex threshold diagrams by plotting 
the point of intersection for mean cluster probability and mean DBP. The operating point 
for AP baroreflex sensitivity was determined by plotting the point of intersection for the 
mean number of unique AP clusters per heartbeat and the mean DBP. 
4.2.7 Statistical Analysis  
A two-way repeated measures analysis of variance (RM ANOVA) assessed the impact of 
experimental condition and AP cluster on the slope of the AP level baroreflex threshold 
relationship. Main effects (i.e., condition, AP cluster) and interactions (i.e., condition-by-
AP cluster) were tested. Hypothesis-driven planned contrasts were executed using one-
tailed paired t-tests to inspect significant interactions. Paired sample t-tests examined the 
impact of condition on hemodynamic, integrated burst and AP indices, and baroreflex 
variables. Values are mean ± SE. Tests were two-tailed unless otherwise specified, with 
a = 0.05. Statistical analyses were performed with SPSS Statistics (v 25, IBM Corp., 




Fig. 4.1 depicts the representative hemodynamic and sympathetic neural emissions at 
BSL and LBNP. Compared to baseline, burst occurrence and amplitude increased with 
LBNP (Table 4.1). Augmented integrated bursting behaviour during LBNP was 
associated with an increase in AP occurrence and AP content per heartbeat compared to 
BSL, which was attributed to an increase in the firing probability of previously active 
APs and the recruitment of larger latent APs (Table 4.1). Fig 4.2 illustrates AP discharge 
by cluster over time as a function of DBP in a single individual at BSL and LBNP. A 
total of 254 ± 22 s of data were analyzed at BSL and 182 ± 22 s during LBNP.  
Fig. 4.3 illustrates the mean regression outcomes calculated for the baroreflex threshold 
and sensitivity diagrams for integrated sympathetic bursts during BSL and LBNP. Under 
BSL conditions, the baroreflex strongly regulated burst occurrence [slope (b): - 3.8 ± 0.4 
%/mmHg, y-intercept (y-int): 302 ± 31 %, r = -0.89 ± 0.03], but exhibited weaker control 
(P value for b comparison: < 0.05) over normalized burst amplitude (b: -1.4 ± 0.4 
AU/mmHg, y-int: 144 ± 29 AU, r = -0.21± 0.1). Compared to BSL, neither the slope of 
the baroreflex threshold (b: -4.1 ± 0.8 %/mmHg, y-int: 357 ± 75 %, r = 0.89 ± 0.02) or 
sensitivity (b: -0.7 ± 0.5 AU/mmHg, y-int: 125 ± 38 AU, r = - 0.04 ± 0.1) relationships 
were altered with LBNP (both P > 0.05). However, the operating points for both 
baroreflex threshold [BSL (DBP, probability): 71 ± 3 mmHg, 31 ± 3 %; LBNP (DBP, 
probability): 75 ± 2 mmHg, 51 ± 4 %] and sensitivity relationships [BSL (DBP, 
normalized amplitude): 71 ± 3 mmHg, 44 ± 3 AU; LBNP (DBP, normalized amplitude): 
75 ± 2 mmHg, 73 ± 8 AU] were reset rightwards (P < 0.05) and upwards (P < 0.05) from 
BSL to LBNP.  
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Fig. 4.4 shows the mean baroreflex threshold relationships calculated for 15 normalized 
clusters at BSL and LBNP. At BSL, the strength of baroreflex control over AP 
occurrence varied by AP size, such that medium APs expressed the greatest threshold 
slopes, while the smallest (BSL normalized cluster 3 vs. BSL normalized cluster 1: P < 
0.05) and largest (BSL normalized cluster 3 vs. BSL normalized cluster 7: P < 0.05) 
active clusters exhibited lesser threshold slopes. The change in baroreflex threshold slope 
from BSL to LBNP varied by AP cluster size (Condition: P < 0.05, Cluster: P < 0.05, 
Condition-by-Cluster: P < 0.05). Specifically, medium AP slopes increased with LBNP, 
while the slopes for the smallest and largest APs present at BSL exhibited a reduction and 
no change respectively, compared to BSL. The larger AP clusters which were silent at 
BSL and recruited with LBNP fired with low probabilities at LBNP and expressed weak 
baroreflex threshold slopes (LBNP normalized cluster 4 vs. LBNP normalized cluster 14: 
P < 0.05). Fig. 4.5 illustrates the interactive effects of condition and cluster on the slope 
of AP baroreflex threshold relationship. At BSL and LBNP, the mean Pearson’s 
correlation statistics for the threshold relationships were stronger than r = - 0.50 for all 
normalized clusters, with the exception of cluster 1 (r = -0.49 ± 0.10), cluster 2 (r = -0.36 
± 0.10), and cluster 15 (r = -0.45 ± 0.13) firing during LBNP. Males and females 
expressed similar changes in baroreflex control of AP discharge from BSL to LBNP. 
Inspection of operating points by cluster (Fig. 4.4) demonstrated that the AP clusters 
expressed non-uniform firing probabilities, where the medium APs exhibited the greatest 
probabilities and the smallest (BSL normalized cluster 3 vs. BSL normalized cluster 1: P 
< 0.05) and largest APs (BSL normalized cluster 3 vs. BSL normalized cluster 7: P < 
0.05) present at BSL fired less often. The operating points of medium clusters (e.g., 
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normalized clusters 3 to 8) were reset upwards (P < 0.05) and rightwards with LBNP (P 
< 0.05), while the operating points of smaller and larger clusters active at BSL were only 
shifted rightwards (Condition: P < 0.05, Cluster: P < 0.05, Condition-by-Cluster: P < 
0.05).  
Last, Fig. 4.6 highlights the mean baroreflex sensitivity relationships for AP cluster 
behaviour at BSL (b: -0.12 ± 0.03 AP clusters/beat/mmHg, y-int: 12 ± 3 AP 
clusters/beat) and LBNP (b: -0.22 ± 0.1 AP clusters/beat/mmHg, y-int: 21 ± 4 AP 
clusters/beat). A weak slope was observed for the baroreflex sensitivity relationship at 
BSL and was unchanged, but the operating point was reset rightwards (P < 0.05) and 
upwards (P < 0.05) with LBNP [BSL (DBP, AP clusters/beat): 71 ± 3 mmHg, 3 ± 0.3 AP 
clusters/beat; LBNP (DBP, AP clusters/beat): 75 ± 2 mmHg, 5 ± 1 AP clusters/beat]. 
Weak Pearson correlation coefficients were observed for the AP cluster baroreflex 
sensitivity relationships under both conditions (BSL: r = - 0.25 ± 0.1, LBNP: r = - 0.37 ± 
0.1).   
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Table 4.1 Hemodynamic variables, integrated, and action potential level indices of 


























Figure 4.1 Data from a single individual illustrating hemodynamic data, integrated 
muscle sympathetic nerve activity (MSNA) and filtered MSNA at baseline (BSL) and 





















Figure 4.2 Data from a single individual illustrating the pattern of action potential (AP) 
discharge over time as a function of their diastolic blood pressure (DBP; top) and cluster 
(left) at baseline (BSL) (A) and lower body negative pressure (LBNP; -80 mmHg in this 
example) (B). AP cluster refers to all APs of similar morphology and are normalized 
between conditions to ensure within-participant comparisons (e.g., cluster 1 represents 












Figure 4.3 Mean baroreflex threshold relationships for the integrated muscle sympathetic 
nerve activity (MSNA) burst occurrence (A) and mean baroreflex sensitivity relationships 
for normalized integrated MSNA burst size at baseline (BSL) and lower body negative 
pressure (LBNP) (B). Filled and empty circles with error bars (SE) represent the 





Figure 4.4 Mean baroreflex threshold relationships between action potential (AP) 
discharge probability and diastolic blood pressure (DBP) for 15 normalized clusters at 
baseline (BSL) and lower body negative pressure (LBNP). Filled and open circles with 















Figure 4.5 Mean baroreflex threshold slopes for 15 normalized action potential (AP) 
clusters at baseline (BSL) and lower body negative pressure (LBNP). Means and SE are 
presented. This figure represents the slopes of the baroreflex threshold relationships 











Figure 4.6 Mean baroreflex sensitivity relationship between the number of action 
potential (AP) clusters per beat and diastolic blood pressure (DBP) at baseline (BSL) and 
lower body negative pressure (LBNP). Filled and open circles with error bars (SE) 





The present study exposed new knowledge regarding the baroreflex mechanisms 
contributing to elevated sympathetic AP discharge during orthostatic stress. First, we 
identified that the baroreflex gain for APs active at BSL becomes modified during LBNP. 
However, LBNP-mediated modifications to baroreflex gain varied by AP cluster size 
such that the slopes for medium-sized APs increased with LBNP, while the slopes for the 
smallest and largest APs active at BSL exhibited a reduction and no change, respectively, 
compared to BSL. Also, new and larger APs that were silent at BSL and recruited with 
LBNP expressed weak baroreflex control. Examining baroreflex control of MSNA using 
integrated measures concealed the impact of LBNP as the strength of baroreflex control 
over burst occurrence and burst size was unchanged from BSL to LBNP. We interpret 
these findings to suggest that when defending blood pressure during orthostatic stress, 
baroreflex control of a discrete group of medium-sized sympathetic APs active at 
baseline becomes enhanced concurrent with an increase in firing rate. Also, the findings 
suggest further that the recruitment process that leads to the appearance of larger AP 
clusters during LBNP that were not present at baseline, is not due to a baroreflex 
mechanism. 
In the present study, a collection of medium clusters (e.g., normalized clusters 4 to 8) 
exhibited augmented baroreflex gain concomitant with a relocation of the baroreflex 
slopes to greater firing probabilities and elevated DBP from BSL to LBNP. Some of 
these AP clusters expressed strong baroreflex slopes and fired with high probabilities at 
BSL (i.e., normalized clusters 4 and 5). This observation replicates findings from our 
previous investigation with a different group of participants (31). Of note, however, both 
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the gain and operating point of these high probability AP clusters were reset during 
LBNP. Thus, it appears that the baroreflex strongly controls the behaviour of most 
medium APs. Fundamentally, enhanced baroreflex control during LBNP enables greater 
inhibitory control to prevent exaggerated sympathetic arousal during orthostatic stress 
(41) but also greater AP firing for a given change in DBP.  
Unlike medium AP clusters, the largest AP clusters active during BSL expressed weak 
baroreflex control that was unchanged with LBNP (i.e., normalized clusters 9 to 13). 
Whether greater levels of baroreflex stress than those imposed here could have 
augmented the baroreflex gain for these APs remains to be tested but we suspect that the 
likelihood remains low as these APs appear to be governed primarily by other neural 
inputs (1, 35). Similarly, we found the largest APs that were previously silent at BSL and 
recruited during LBNP express weak baroreflex slopes in all participants (i.e., normalized 
clusters 14 and 15). This finding aligns with our previous observation that this AP 
subpopulation was only recruited during severe levels of baroreflex stress (29). Here, 
even during baroreflex stimuli sufficient for recruitment, the baroreflex only weakly 
governed the moment-to-moment discharge of these APs. We suspect that either a 
threshold of baroreflex unloading must be reached to withdraw baroreflex-inhibition over 
the central neural region(s) primarily governing this subpopulation or some other non-
baroreflex mechanism recruited these APs. Indeed, many forms of physiological stress 
recruit previously silent larger and faster conducting APs including those activating the 
arterial chemoreflex and muscle metaboreflex along with manoeuvres involving 
volitional effort or perceptual stress (e.g., Valsalva’s Manoeuvre, voluntary apnea) (1, 15, 
30, 32, 34, 35). In these other manoeuvres, it remains possible that baroreflex resetting is 
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responsible for the recruitment of previously silent APs. However, the current data argue 
against that mechanism. Rather, the present results support the hypothesis that large AP 
clusters, including those firing infrequently at BSL and the subpopulation of latent, high-
threshold APs receive a variety of neural inputs, but baroreflex afferents do not represent 
the dominant source (19, 22). The organization of baroreflex inputs within medullary 
brainstem nuclei and/or direct projections from supra-medullary sites (e.g., 
paraventricular nucleus of the hypothalamus, caudal raphe nuclei, pons) to spinal 
preganglionic neurons may contribute to reduced baroreflex control of larger sympathetic 
axons (4, 21, 36). 
In the current study, the cluster of the smallest APs (i.e., normalized cluster 1) expressed 
intriguing baroreflex control. In the BSL condition, the small APs demonstrated lesser 
baroreflex gain compared to medium-sized clusters. Previously our laboratory reported 
reduced baroreflex control as AP size increased, yet individual data figures presented in 
this earlier study do hint at the BSL behaviour illustrated here (31). This pattern was 
likely exposed more clearly in the present study by cluster normalization and because we 
extracted all detected APs regardless of if they fired within or between bursts, whereas 
our previous study focused solely on the synchronized APs forming integrated bursts 
(31). This analysis strategy was based on a recent observation that about 30% of 
sympathetic APs at BSL fire asynchronously between MSNA bursts in healthy young 
individuals, with the smallest APs expressing the greatest proportion of asynchronous 
activity (17). While we did not examine the baroreflex gain of synchronous and 
asynchronous APs separately here, reduced baroreflex control of small APs may 
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represent an additional mechanism contributing to asynchronous behaviour of this 
subpopulation in our previous study.   
Compared to BSL, the cluster of the smallest APs (e.g., normalized cluster 1) showed 
reductions in baroreflex gain but no change in firing probability during LBNP, pointing 
to diminished baroreflex regulation during orthostatic stress. No previous study has 
investigated baroreflex control of AP occurrence during physiological stress, but some 
insight may be gained from earlier investigations of multi-unit AP discharge during 
baroreflex stress. Using the wavelet approach to extract APs firing within bursts, Limberg 
and colleagues (18) observed a paradoxical reduction in the smallest AP cluster firing 
probability during orthostatic stress imposed by sodium nitroprusside infusion. Also, the 
single-unit technique has exposed a subpopulation of APs that display paradoxical 
reductions in firing frequency during modest LBNP (13, 23). Overall, these data indicate 
that the small APs are regulated primarily by non-baroreflex processes and/or may be 
inhibited by baroreflex unloading. 
The mechanisms underlying modifications in baroreflex control across the size-range of 
AP subpopulations remain unclear. Baroreflex slopes were calculated from spontaneous 
pressure fluctuations that were not large enough to estimate the complete baroreflex 
sigmoid for the various AP clusters this study. While the baroreflex sigmoid relationship 
(6, 27) remains to be derived for sympathetic discharge at the AP level, we speculate that 
for medium AP clusters, the baroreflex functions are shifted to higher levels of activity 
and greater DBPs, and that the operating points relocate to regions of greater gain during 
orthostatic stress. Based on the variability in baroreflex slope and operating point among 
medium clusters at BSL and LBNP, we hypothesize that of the medium-sized APs under 
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strong baroreflex control, the position of the operating point and/or morphology of the 
baroreflex sigmoid may depend on AP size. The alterations in baroreflex function from 
BSL to LBNP observed here may be linked to reductions in pulse pressure detected by 
arterial baroreceptors, or relocation of venous blood detected by cardiopulmonary 
baroreceptors and/or venous mechanoreceptors (3, 25). Also, descending neural signals 
related to the perception of effort accompanying the muscular contraction required to 
resist suction during LBNP may have shaped baroreflex behaviour in this study (26). 
Historically, baroreflex control of MSNA has been quantified by relying on the integrated 
signal to examine the relationship between burst occurrence or burst size and DBP (14, 
38). In the present study, we replicated findings from our laboratory and others indicating 
that under BSL conditions, the arterial baroreflex strongly governs burst occurrence and 
only weakly controls burst size (12, 14, 20, 31). Consistent with previous research (11, 
12), we observed no change in the strength of baroreflex control over integrated burst 
probability or burst size from BSL to LBNP, but the operating points were shifted to 
higher levels of activity and greater DBP. The finding that LBNP did not impact the weak 
baroreflex regulation of burst size can be explained by the following: 1) Burst size is a 
function of the number and size of APs, with larger APs contributing mainly to larger 
bursts (35), and 2) LBNP did not impact the strength of baroreflex control over the 
number of unique clusters per beat or the occurrence of the largest APs. Why baroreflex 
control of integrated burst occurrence remained unchanged from BSL to LBNP despite 
enhanced baro-control of medium APs (which fire in most bursts) remains unclear. Only 
the upward and rightward shifts in medium AP operating points were mirrored in the 
integrated baroreflex threshold operating point. Perhaps the heterogeneous changes in 
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baroreflex control of differently AP subpopulations rendered the slope of the integrated 
baroreflex threshold relationship unchanged due to the averaging impact of the 
integration process.  
4.4.1 Conclusion 
The present study discovered that the baroreflex gain of the subpopulation of medium-
sized sympathetic APs that were active under BSL conditions becomes enhanced and 
reset to higher levels of activity to facilitate elevated sympathetic discharge during 
LBNP. The large APs present under BSL conditions and the subpopulation of larger APs 
that were silent at BSL but recruited during LBNP were under weak, if any, baroreflex 
control. Clusters of small APs, which express weak baroreflex control under baseline 
conditions exhibit paradoxical reductions in gain during LBNP. Also, the baroreflex 
expressed minimal control over the number of unique AP clusters firing per beat under 
both conditions. Thus, baroreflex control represents only one input to sympathetic 
activation during orthostatic stress. Baroreflex control appears to form a modifiable 
mechanism –– at least for a discrete subpopulation of medium-sized APs –– enabling 
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5 General Discussion 
The studies comprising the present dissertation provide new knowledge regarding the 
behaviour of, and mechanisms governing, low-threshold sympathetic APs: APs that are 
active during baseline conditions and some of which exhibit augmented firing during 
physiological stress. We illustrated that sympathetic c-fibre discharge results from the 
integration of arterial baroreflex and yet unknown non-baroreflex inputs within the 
central sympathetic circuitry, and contributions from the paravertebral ganglia, where 
interactions between nicotinic and non-nicotinic neurotransmission along with varying 
patterns of pre-to-postganglionic innervation exist. Consequently, low-threshold APs do 
not express uniform behaviour, but rather function as discrete subpopulations related to 
postganglionic AP size (reflecting different sized axons) that receive differential 
regulation and express varying firing properties, during baseline conditions and 
physiological stress. Consistently, the discharge probability among low-threshold APs 
relates to AP cluster size in a manner that resembles an inverted “U” distribution.  
Collectively, the data generated by these studies indicate that the subpopulation of 
medium APs fires synchronously within most bursts of MSNA [Study One (10), Study 
Two (11), and Study Three] as a result of upstream neurons linked to this postganglionic 
subpopulation receiving strong baroreflex regulation (Study Three) and predominantly 
nicotinic mechanisms at the ganglia (Study One). During baroreflex stress imposed by 
mild to severe LBNP, the firing probability of medium APs becomes increased (i.e., rate-
coding mechanism) as a result of an upward resetting in the baroreflex control and 
relocation of the operating point to a position of enhanced gain (Study Three). It should 
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be noted however, that even within the subpopulation of medium APs under baroreflex 
control some variability exists in baseline firing probabilities, baroreflex gain, and the 
responses to baroreflex stress, which we hypothesize stems from baroreflex sigmoid 
morphology and characteristics (e.g., operating point location) varying by AP size (21). 
Based on these observations we suspect that this subpopulation of APs aligns with those 
recorded using the single-unit technique, particularly the seminal investigations by 
Macefield and colleagues (15, 16). These studies observed most APs to fire once per 
burst during periods of baroreceptor unloading accompanying transient reductions in 
blood pressure under baseline conditions and express the capacity to increase firing 
probability during physiological stress (15, 16). Also, the consistent finding that 
integrated bursts are abolished by trimethaphan (1, 2, 5) aligns with the conclusion that 
medium APs contribute to most bursts and are primarily governed by nicotinic ganglionic 
neurotransmission.  
Combined, the present findings suggest that the regulatory mechanisms governing the 
subpopulation of small sympathetic APs are fundamentally different than those regulating 
medium APs, both within the central circuitry and at the ganglia. This dissertation 
highlights that non-baroreflex mechanisms form the primary input to the upstream nerves 
linked to this subpopulation of smaller APs. For example, under baseline conditions, the 
small APs expressed low firing probabilities (Study One) and when we examined all APs 
rather than just those within integrated bursts, this subpopulation exhibited the greatest 
proportion of asynchronous discharge, indicating that their firing was not initiated in 
diastole or terminated in systole by baroreflex mechanisms (Study Two). Also, the 
clusters of the small APs did not respond to baroreflex stress imposed by Valsalva’s 
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Manoeuvre performed during the trimethaphan infusion — where only this subpopulation 
persisted to fire (Study One) — or during varying levels of LBNP (Studies Two and 
Three). Also, small APs exhibited weak baroreflex slopes during baseline conditions, 
then demonstrated paradoxical reductions in baroreflex gain on going from baseline to 
LBNP (Study Three). Likewise, Limberg and colleagues (12) observed that the smallest 
APs fired with reduced probability (less often) during the hypotensive phase of a 
modified Oxford protocol performed in healthy participants. The collective evidence also 
suggests that non-nicotinic mechanisms at the paravertebral ganglia primarily initiate the 
depolarization of this subpopulation of small APs. Indeed, trimethaphan infusion under 
baseline conditions blocked medium and larger AP subpopulations thereby abolishing 
integrated bursts of MSNA, but the small APs persisted to fire in an asynchronous 
manner (Study One). Upon retrospective analysis of these data focusing on between-burst 
AP emissions (Study Two), we identified that small APs firing asynchronously also 
survived trimethaphan. Thus, small APs may arise from postganglionic nerves activated 
by muscarinic or non-cholinergic receptors, which have been found to contribute to 
ganglionic neurotransmission in lower animals (7–9). In addition to weak baroreflex 
control centrally, non-nicotinic ganglionic mechanisms may contribute to asynchronous 
firing of small APs (3, 4).  
In contrast to the medium sized AP clusters, large APs are observed to fire infrequently 
during baseline conditions. The present studies highlight new information that this 
subpopulation of large APs active under baseline conditions represent a subpopulation of 
postganglionic axons regulated primarily by non-baroreflex inputs within the central 
sympathetic organization and nicotinic mechanisms at the ganglia. We infer minimal 
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baroreflex regulation of this subpopulation based on the finding that under baseline 
conditions large APs fired infrequently (Studies One, Two, and Three) and expressed 
weak baroreflex slopes (Study Three), then exhibited no change in discharge rate or 
baroreflex gain during baroreflex unloading with LBNP (Study Three). However, we 
speculate that the central non-baroreflex mechanisms governing larger low-threshold APs 
may differ from those regulating the smallest APs as these subpopulations express 
incongruent responses in baroreflex gain during LBNP (Study Three). Specifically, while 
the smallest APs expressed reductions in baroreflex gain, the large APs demonstrated no 
change in baroreflex control from baseline to LBNP (Study Three). Both previously 
active APs and the subpopulation of larger latent APs may be regulated by other 
peripheral reflexes other than the baroreflex. For example, studies in humans and animals 
illustrate that chemoreflex stress preferentially augments burst amplitude, reflecting 
higher probability of larger AP discharge (17, 23). The PVN hypothalamus and 
periaqueductal gray may also contribute to the regulation of larger APs as animal and 
human studies found that activation of these sites (chemical or electrical stimulation) to 
increase burst size (18, 24). At the ganglia, the finding that larger APs active under 
baseline conditions were de-recruited first by trimethaphan suggests that the 
postganglionic axons generating these APs are activated primarily by nicotinic receptors 
(Study One). However, we suspect that the patterns of pre-to-postganglionic innervation 
vary by sympathetic c-fibre size given the progressive AP blockade (with the exception 




The present studies further our understanding of the sympathetic emissions directed 
towards the vasculature supplying skeletal muscle and the mechanisms affecting these 
neural patterns. However, this series of studies generated several key questions regarding 
the neural processes shaping sympathetic outflow. Specifically, the central networks (i.e., 
supra-spinal and spinal) shaping the behaviour of varying-sized low-threshold APs along 
with the recruitment of previously-silent larger APs remain unclear. Techniques 
involving simultaneous multi-fibre microneurography and functional magnetic resonance 
imaging or stimulation of implanted electrodes may yield new information in this area 
(13, 24). For example, by performing microneurography at the same time as functional 
imaging in healthy humans, Macefield and colleagues (13, 14) found baseline 
sympathetic burst amplitude to relate to the activation of a functional network of nuclei 
comprised by the insula, hypothalamus, periaqueductal gray, and RVLM. Consistent with 
this finding, stimulation of the dorsolateral periaqueductal gray via implanted deep brain 
electrodes produced larger sympathetic bursts compared to pre-stimulation conditions 
(24). Although inferences may be drawn regarding the impact of these regions on AP 
discharge and/or recruitment, microneurographic studies examining AP behaviour within 
these experimental paradigms remain to be conducted. Continued used of 
pharmacological agents will also reveal intricacies within the sympathetic organization 
(10, 25). For example, pharmacological blockade and activation of the widely centrally 
distributed GABA receptors (25) and a2R (26), respectively, have demonstrated 
sympathoinhibitory effects, but the influence of the underlying AP patterns remain 
concealed by signal integration. Basic studies of this sort are paramount to identifying the 
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critical elements of the sympathetic system that contribute to aberrant and overactive 
discharge patterns which are hallmark of cardiovascular and neurological pathologies (6, 
22).  
5.2 Conclusion 
The present studies nuanced the complexity of the sympathetic discharge patterns 
employed to communicate the appropriate circulatory adjustments for homeostatic 
maintenance and the mechanisms subserving these neural behaviours in healthy humans. 
Indeed, the arterial baroreflex does not exert strong control over all sympathetic AP 
subpopulations and extra-baroreflex processes, both centrally and peripherally, govern 
AP discharge. At the paravertebral ganglia, both nicotinic and non-nicotinic mechanisms, 
as well as varying degrees of pre-to-postganglionic innervation affect sympathetic AP 
discharge. The sympathetic neural architecture produces heterogeneous firing properties 
that vary by AP size, such that the distribution of within-burst firing probabilities 
resembles an inverted “U” shape under baseline conditions: medium APs fire in most 
bursts and the small and large APs discharge infrequently. However, as a result of weak 
baroreflex control and non-nicotinic ganglionic neurotransmission, not all AP discharge 
occurs synchronously within bursts, as ~30% of total APs fire asynchronously between 
bursts of activity at baseline, with the smallest APs expressing the greatest proportion of 
asynchronous activity. During baroreflex stress, the sympathetic system increases total 
MSNA by increasing the firing probabilities of previously-active low-threshold APs, and 
recruiting a subpopulation of larger latent APs. However, not all low-threshold APs 
participate in the rate-coding strategy for increasing total MSNA, as only the medium 
APs under strong baroreflex control at baseline are reset upwards with operating points 
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Doctoral Scholarship (PGS D). $42,000. Western University. September 2017- 
August 2019. 
 
3. Ontario Graduate Scholarship (OGS) Doctoral Award. $15,000. Western University. 
September 2017-August 2018. Declined. 
 
4. Ontario Graduate Scholarship (OGS) Doctoral Award. $15,000. Western University. 
September 2016-August 2017. 
 
5. Ontario Graduate Scholarship (OGS) Doctoral Award. $15,000. Western University. 
September 2015-August 2016. 
 
6. Ontario Graduate Scholarship (OGS) Masters Award. $15,000. Brock University. 
September 2014-August 2015. 
 
Honours and Awards 
 
1. School of Kinesiology Graduate Travel Award. $417. Western University. August 
2019.  
 
2. International Society for Autonomic Neuroscience Geoffrey Burnstock Poster 
Presentation Award. $ 500 Euros. July 2019.  
 
3. Graduate Student Teaching Assistant Award Nomination. Western University. June 
2019.  
 
4. Canadian Institutes of Health Research in partnership with the Institute of 
Community Support and the Institute for Circulatory and Respiratory Health Travel 
Award. $1,000. April 2019 
 
5. American Physiological Society International Early Career Physiologist Travel 
Award. $1,000 USD. April 2019. 
 
6. American Physiological Society Neural Control and Autonomic Regulation Section 
Experimental Biology Trainee Award. $500 USD. April 2019. 
 
7. School of Kinesiology Graduate Travel Award. $500. Western University. June 
2018.  
 
8. Faculty of Health Sciences (FHS) Graduate Travel Award. $250. Western 
University. April 2018.  
 
9. Canadian Institutes of Health Research in partnership with the Institute of 
Community Support and the Institute for Circulatory and Respiratory Health Travel 




10. Caroline Tum Suden Professional Opportunity Award. American Physiological 
Society. $585 USD. January 2018. 
 
11. School of Kinesiology Graduate Travel Award. $500. Western University. April 
2017.  
 
12. Faculty of Health Sciences (FHS) Graduate Travel Award. $250. Western 
University. November 2016. 
 
13. Faculty of Health Sciences (FHS) Tri-council Scholarship Application Review 
Award. $1,000. Western University. November 2016. 
 
14. Dean of Graduate Studies Award. $2,500. Brock University. September 2014-August 
2015. 
 
15. Dean of Graduate Studies Award. $2,000. Brock University. September 2013-August 
2014. 
 
16. First Class Standing in Applied Health Sciences. Brock University. June 2013. 
 
17. Dean’s Honour List in Applied Health Sciences. Brock University. September 2009-
April 2013. 
 
18. Brock University Entrance Scholarship (93+% average). $14,000. Brock University. 
September 2009-April 2013. 
 
 
Service: Community and Committee Involvement 
 
1. Science Outreach Workshop (classroom and laboratory demonstrations) for Grade 
7/8 class from Sacred Heart Catholic School. “How the cardiovascular system serves 
our lives”. May 13, 2019. 
 
2. Editorial Activity: American Journal of Physiology – Heart and Circulatory 
Physiology. Manuscripts reviewed: 1. 2019-present. 
 
3. Abstract Committee Member for the 2017 Western Exercise is Medicine Conference. 
Exercise is Medicine National Conference at Western University. April-June 2017. 
 
4. Editor of the Brock Health Magazine Issues 10 and 11. Brock University. September 
2014-August 2015. 
 
5. "Scientifically Yours" Project Leader-Health and Human Performance Workshop. 




6. Inaugural Elected Executive Member of the Brock University Chapter of the 
Canadian Coalition for Global Health Research. Brock University. May 2014-August 
2015. 
 
7. Congress of the Humanities and Social Sciences Conference. Support Staff. Brock 
University. 2014.  
 
8. Head Coach for the Bantam Boys St. Catharines Cobras Baseball Team. St. 
Catharines. 2014.  
 
9. Volunteer exercise-rehabilitation supervisor for the Brock-Niagara Centre for Health 
and Well-Being. Brock University. 2013-2015. 
